{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:08:52Z","timestamp":1794262132039,"version":"4.9.0"},"reference-count":431,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Centre for Misfolding Diseases"},{"DOI":"10.13039\/100019923","name":"DEVCOM-ARL","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019923","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000774","name":"DTRA","doi-asserted-by":"crossref","award":["SARI"],"award-info":[{"award-number":["SARI"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009888","name":"Regione Toscana","doi-asserted-by":"publisher","award":["Project PRAMA"],"award-info":[{"award-number":["Project PRAMA"]}],"id":[{"id":"10.13039\/501100009888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The conversion of native peptides and proteins into amyloid aggregates is a hallmark of over 50 human disorders, including Alzheimer\u2019s and Parkinson\u2019s diseases. Increasing evidence implicates misfolded protein oligomers produced during the amyloid formation process as the primary cytotoxic agents in many of these devastating conditions. In this review, we analyze the processes by which oligomers are formed, their structures, physicochemical properties, population dynamics, and the mechanisms of their cytotoxicity. We then focus on drug discovery strategies that target\u00a0the formation of oligomers\u00a0and their ability to disrupt cell physiology and trigger degenerative processes.<\/jats:p>","DOI":"10.1186\/s13024-023-00651-2","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T07:04:41Z","timestamp":1708412681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":139,"title":["Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases"],"prefix":"10.1186","volume":"19","author":[{"given":"Dillon J.","family":"Rinauro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Vendruscolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6030-6656","authenticated-orcid":false,"given":"Ryan","family":"Limbocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"651_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti F, Dobson CM. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem. 2017;86:27\u201368.","journal-title":"Annu Rev Biochem"},{"key":"651_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nrm3810","volume":"15","author":"TPJ Knowles","year":"2014","unstructured":"Knowles TPJ, Vendruscolo M, Dobson CM. The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol. 2014;15:384\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"651_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8:595\u2013608.","journal-title":"EMBO Mol Med"},{"key":"651_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","volume":"598","author":"Y Shi","year":"2021","unstructured":"Shi Y, Zhang W, Yang Y, Murzin AG, Falcon B, Kotecha A, et al. Structure-based classification of tauopathies. Nature. 2021;598:359\u201363.","journal-title":"Nature"},{"key":"651_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.abm7285","volume":"375","author":"Y Yang","year":"2022","unstructured":"Yang Y, Arseni D, Zhang W, Huang M, L\u00f6vestam S, Schweighauser M, et al. Cryo-EM structures of amyloid-\u03b2 42 filaments from human brains. Science. 2022;375:167\u201372.","journal-title":"Science"},{"key":"651_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/13506129.2022.2147636","volume":"29","author":"JN Buxbaum","year":"2022","unstructured":"Buxbaum JN, Dispenzieri A, Eisenberg DS, F\u00e4ndrich M, Merlini G, Saraiva MJM, et al. Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 2022;29:213\u20139.","journal-title":"Amyloid"},{"key":"651_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"G Merlini","year":"2003","unstructured":"Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349:583\u201396.","journal-title":"N Engl J Med"},{"key":"651_CR8","doi-asserted-by":"crossref","unstructured":"Wood JG, Mirra SS, Pollock NJ, Binder LI. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc Natl Acad Sci. 1986;83:4040\u20133.","DOI":"10.1073\/pnas.83.11.4040"},{"key":"651_CR9","doi-asserted-by":"crossref","unstructured":"Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem. 1986;261:6084\u20139.","DOI":"10.1016\/S0021-9258(17)38495-8"},{"key":"651_CR10","doi-asserted-by":"crossref","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s Disease: The amyloid cascade hypothesis. Science. 1992;256:184\u20135.","DOI":"10.1126\/science.1566067"},{"key":"651_CR11","doi-asserted-by":"crossref","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci. 1985;82:4245\u20139.","DOI":"10.1073\/pnas.82.12.4245"},{"key":"651_CR12","doi-asserted-by":"crossref","unstructured":"Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M. \u03b1-Synuclein in Lewy bodies. Nature. 1997;388:839\u201340.","DOI":"10.1038\/42166"},{"key":"651_CR13","doi-asserted-by":"crossref","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc Natl Acad Sci U S A. 1998;95:6469\u201373.","DOI":"10.1073\/pnas.95.11.6469"},{"key":"651_CR14","doi-asserted-by":"crossref","unstructured":"Palato LM, Pilcher S, Oakes A, Lamba A, Torres J, Ledesma Monjaraz LI, et al. Amyloidogenicity of naturally occurring fulllength animal IAPP variants. J Pept Sci. 2019;25:e3199.","DOI":"10.1002\/psc.3199"},{"key":"651_CR15","doi-asserted-by":"crossref","unstructured":"Westermark P, Wernstedt C, Wilander E, Sletten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun. 1986;140:827\u201331.","DOI":"10.1016\/0006-291X(86)90708-4"},{"key":"651_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"651_CR17","doi-asserted-by":"crossref","unstructured":"Sengupta U, Nilson AN, Kayed R. The role of amyloid-\u03b2 oligomers in toxicity, propagation, and immunotherapy. eBioMedicine. 2016;6:42\u20139.","DOI":"10.1016\/j.ebiom.2016.03.035"},{"key":"651_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1326-6-39","volume":"6","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol Neurodegener. 2011;6:39.","journal-title":"Mol Neurodegener"},{"key":"651_CR19","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1093\/hmg\/ddab363","volume":"31","author":"F Du","year":"2022","unstructured":"Du F, Yu Q, Kanaan NM, Yan SS. Mitochondrial oxidative stress contributes to the pathological aggregation and accumulation of tau oligomers in Alzheimer\u2019s disease. Hum Mol Genet. 2022;31:2498\u2013507.","journal-title":"Hum Mol Genet"},{"key":"651_CR20","doi-asserted-by":"crossref","unstructured":"Guerrero-Mu\u00f1oz MJ, Gerson J, Castillo-Carranza DL. Tau oligomers: The toxic player at synapses in alzheimer\u2019s disease. Front Cell Neurosci. 2015;9:1\u201310. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2015.00464.","DOI":"10.3389\/fncel.2015.00464"},{"key":"651_CR21","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1073\/pnas.1218402110","volume":"110","author":"SIA Cohen","year":"2013","unstructured":"Cohen SIA, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, et al. Proliferation of amyloid-\u03b242 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci USA. 2013;110:9758\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR22","doi-asserted-by":"publisher","first-page":"9384","DOI":"10.1073\/pnas.1401564111","volume":"111","author":"G Meisl","year":"2014","unstructured":"Meisl G, Yang X, Hellstrand E, Frohm B, Kirkegaard JB, Cohen SIA, et al. Differences in nucleation behavior underlie the contrasting aggregation kinetics of the A\u03b240 and A\u03b242 peptides. Proc Natl Acad Sci USA. 2014;111:9384\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR23","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1021\/acschemneuro.1c00454","volume":"12","author":"DC Rodriguez Camargo","year":"2021","unstructured":"Rodriguez Camargo DC, Sileikis E, Chia S, Axell E, Bernfur K, Cataldi RL, et al. Proliferation of Tau 304\u2013380 fragment aggregates through autocatalytic secondary nucleation. ACS Chem Neurosci. 2021;12:4406\u201315.","journal-title":"ACS Chem Neurosci"},{"key":"651_CR24","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1073\/pnas.0712290105","volume":"105","author":"C Sachse","year":"2008","unstructured":"Sachse C, F\u00e4ndrich M, Grigorieff N. Paired \u03b2-sheet structure of an A\u03b2(1\u201340) amyloid fibril revealed by electron microscopy. Proc Natl Acad Sci USA. 2008;105:7462\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1126\/science.aao2825","volume":"358","author":"L Gremer","year":"2017","unstructured":"Gremer L, Sch\u00f6lzel D, Schenk C, Reinartz E, Labahn J, Ravelli RBG, et al. Fibril structure of amyloid-\u03b2(1\u201342) by cryo\u2013electron microscopy. Science. 2017;358:116\u20139.","journal-title":"Science"},{"key":"651_CR26","doi-asserted-by":"crossref","unstructured":"L\u00f6vestam S, Koh FA, van Knippenberg B, Kotecha A, Murzin AG, Goedert M, et al. Assembly of recombinant tau into filaments identical to those of Alzheimer\u2019s disease and chronic traumatic encephalopathy. eLife. 2022;11:e76494.","DOI":"10.7554\/eLife.76494"},{"key":"651_CR27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023089118","volume":"118","author":"U Ghosh","year":"2021","unstructured":"Ghosh U, Thurber KR, Yau W-M, Tycko R. Molecular structure of a prevalent amyloid-\u03b2 fibril polymorph from Alzheimer\u2019s disease brain tissue. Proc Natl Acad Sci USA. 2021;118: e2023089118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR28","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1038\/s41467-019-12683-8","volume":"10","author":"M Kollmer","year":"2019","unstructured":"Kollmer M, Close W, Funk L, Rasmussen J, Bsoul A, Schierhorn A, et al. Cryo-EM structure and polymorphism of A\u03b2 amyloid fibrils purified from Alzheimer\u2019s brain tissue. Nat Commun. 2019;10:4760.","journal-title":"Nat Commun"},{"key":"651_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ, et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature. 2017;547:185\u201390.","journal-title":"Nature"},{"key":"651_CR30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00401-018-1914-z","volume":"136","author":"B Falcon","year":"2018","unstructured":"Falcon B, Zhang W, Schweighauser M, Murzin AG, Vidal R, Garringer HJ, et al. Tau filaments from multiple cases of sporadic and inherited Alzheimer\u2019s disease adopt a common fold. Acta Neuropathol (Berl). 2018;136:699\u2013708.","journal-title":"Acta Neuropathol (Berl)"},{"key":"651_CR31","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, et al. In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci USA. 2011;108:4194\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR32","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","volume":"13","author":"D Emin","year":"2022","unstructured":"Emin D, Zhang YP, Lobanova E, Miller A, Li X, Xia Z, et al. Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease. Nat Commun. 2022;13:5512.","journal-title":"Nat Commun"},{"key":"651_CR33","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/science.aan6160","volume":"358","author":"G Fusco","year":"2017","unstructured":"Fusco G, Chen SW, Williamson PTF, Cascella R, Perni M, Jarvis JA, et al. Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers. Science. 2017;358:1440\u20133.","journal-title":"Science"},{"key":"651_CR34","doi-asserted-by":"crossref","unstructured":"Horne RI, Metrick MAI, Man W, Rinauro DJ, Brotzakis ZF, Chia S, et al. Secondary processes dominate the quiescent, spontaneous aggregation of \u03b1-synuclein at physiological pH with sodium salts. ACS Chem Neurosci. 2023;14:3125\u201331.","DOI":"10.1021\/acschemneuro.3c00282"},{"key":"651_CR35","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.1073\/pnas.1315346111","volume":"111","author":"AK Buell","year":"2014","unstructured":"Buell AK, Galvagnion C, Gaspar R, Sparr E, Vendruscolo M, Knowles TPJ, et al. Solution conditions determine the relative importance of nucleation and growth processes in \u03b1-synuclein aggregation. Proc Natl Acad Sci USA. 2014;111:7671\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR36","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.36402","volume":"7","author":"R Guerrero-Ferreira","year":"2018","unstructured":"Guerrero-Ferreira R, Taylor NM, Mona D, Ringler P, Lauer ME, Riek R, et al. Cryo-EM structure of alpha-synuclein fibrils. eLife. 2018;7: e36402.","journal-title":"eLife"},{"key":"651_CR37","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","volume":"28","author":"Y Li","year":"2018","unstructured":"Li Y, Zhao C, Luo F, Liu Z, Gui X, Luo Z, et al. Amyloid fibril structure of \u03b1-synuclein determined by cryo-electron microscopy. Cell Res. 2018;28:897\u2013903.","journal-title":"Cell Res"},{"key":"651_CR38","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41594-019-0322-y","volume":"26","author":"DR Boyer","year":"2019","unstructured":"Boyer DR, Li B, Sun C, Fan W, Sawaya MR, Jiang L, et al. Structures of fibrils formed by \u03b1-synuclein hereditary disease mutant H50Q reveal new polymorphs. Nat Struct Mol Biol. 2019;26:1044\u201352.","journal-title":"Nat Struct Mol Biol"},{"key":"651_CR39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle MD, Comellas G, Nieuwkoop AJ, Covell DJ, Berthold DA, Kloepper KD, et al. Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein. Nat Struct Mol Biol. 2016;23:409\u201315.","journal-title":"Nat Struct Mol Biol"},{"key":"651_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang Y, Shi Y, Schweighauser M, Zhang X, Kotecha A, Murzin AG, et al. Structures of \u03b1-synuclein filaments from human brains with Lewy pathology. Nature. 2022;610:791\u20135.","journal-title":"Nature"},{"key":"651_CR41","doi-asserted-by":"crossref","unstructured":"Burger D, Fenyi A, Bousset L, Stahlberg H, Melki R. Cryo-EM structure of alpha-synuclein fibrils amplified by PMCA from PD and MSA patient brains. bioRxiv. 2021;2021.07.08.451588. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2021.07.08.451588v1.","DOI":"10.1101\/2021.07.08.451588"},{"key":"651_CR42","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1038\/s41467-019-13564-w","volume":"10","author":"T Stroh\u00e4ker","year":"2019","unstructured":"Stroh\u00e4ker T, Jung BC, Liou S-H, Fernandez CO, Riedel D, Becker S, et al. Structural heterogeneity of \u03b1-synuclein fibrils amplified from patient brain extracts. Nat Commun. 2019;10:5535.","journal-title":"Nat Commun"},{"key":"651_CR43","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","volume":"27","author":"ML Kramer","year":"2007","unstructured":"Kramer ML, Schulz-Schaeffer WJ. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci. 2007;27:1405\u201310.","journal-title":"J Neurosci"},{"key":"651_CR44","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/brain\/awn349","volume":"132","author":"KE Paleologou","year":"2009","unstructured":"Paleologou KE, Kragh CL, Mann DMA, Salem SA, Al-Shami R, Allsop D, et al. Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain J Neurol. 2009;132:1093\u2013101.","journal-title":"Brain J Neurol"},{"key":"651_CR45","doi-asserted-by":"crossref","unstructured":"Ingelsson M. Alpha-synuclein oligomers\u2014Neurotoxic molecules in parkinson\u2019s disease and other lewy body disorders. Front Neurosci. 2016;10:1\u201310. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2016.00408.","DOI":"10.3389\/fnins.2016.00408"},{"key":"651_CR46","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/acn3.50897","volume":"6","author":"M Bongianni","year":"2019","unstructured":"Bongianni M, Ladogana A, Capaldi S, Klotz S, Baiardi S, Cagnin A, et al. \u03b1-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies. Ann Clin Transl Neurol. 2019;6:2120\u20136.","journal-title":"Ann Clin Transl Neurol"},{"key":"651_CR47","doi-asserted-by":"crossref","unstructured":"Dhavale DD, Barclay AM, Borcik CG, Basore K, Gordon IR, Liu J, et al. Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue. bioRxiv. 2023:2023.01.09.523303. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2023.01.09.523303v1.","DOI":"10.2210\/pdb8fpt\/pdb"},{"key":"651_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/alzrt255","volume":"6","author":"O Hansson","year":"2014","unstructured":"Hansson O, Hall S, Ohrfelt A, Zetterberg H, Blennow K, Minthon L, et al. Levels of cerebrospinal fluid \u03b1-synuclein oligomers are increased in Parkinson\u2019s disease with dementia and dementia with Lewy bodies compared to Alzheimer\u2019s disease. Alzheimers Res Ther. 2014;6:25.","journal-title":"Alzheimers Res Ther"},{"key":"651_CR49","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1471-4159.2004.02533.x","volume":"90","author":"DL Pountney","year":"2004","unstructured":"Pountney DL, Lowe R, Quilty M, Vickers JC, Voelcker NH, Gai WP. Annular \u03b1-synuclein species from purified multiple system atrophy inclusions. J Neurochem. 2004;90:502\u201312.","journal-title":"J Neurochem"},{"key":"651_CR50","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00018-022-04166-9","volume":"79","author":"R Cascella","year":"2022","unstructured":"Cascella R, Bigi A, Cremades N, Cecchi C. Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies. Cell Mol Life Sci. 2022;79:174.","journal-title":"Cell Mol Life Sci"},{"key":"651_CR51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin AG, Ghetti B, et al. Structures of \u03b1-synuclein filaments from multiple system atrophy. Nature. 2020;585:464\u20139.","journal-title":"Nature"},{"key":"651_CR52","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi SJ, Flower MD, Ross CA, Wild EJ. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol. 2020;16:529\u201346.","journal-title":"Nat Rev Neurol"},{"key":"651_CR53","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1021\/acs.accounts.0c00450","volume":"53","author":"R Wetzel","year":"2020","unstructured":"Wetzel R. Exploding the repeat length paradigm while exploring amyloid toxicity in Huntington\u2019s disease. Acc Chem Res. 2020;53:2347\u201357.","journal-title":"Acc Chem Res"},{"key":"651_CR54","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1016\/j.molcel.2022.09.031","volume":"82","author":"MHM Gropp","year":"2022","unstructured":"Gropp MHM, Klaips CL, Hartl FU. Formation of toxic oligomers of polyQ-expanded Huntingtin by prion-mediated cross-seeding. Mol Cell. 2022;82:4290\u20134306.e11.","journal-title":"Mol Cell"},{"key":"651_CR55","doi-asserted-by":"crossref","unstructured":"Sinnige T, Meisl G, Michaels TCT, Vendruscolo M, Knowles TPJ, Morimoto RI. Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in C. elegans. Proc Natl Acad Sci USA. 2021;118:e2021888118.","DOI":"10.1073\/pnas.2021888118"},{"key":"651_CR56","doi-asserted-by":"publisher","first-page":"10723","DOI":"10.1021\/jacs.2c00509","volume":"144","author":"S Nazarov","year":"2022","unstructured":"Nazarov S, Chiki A, Boudeffa D, Lashuel HA. Structural basis of Huntingtin fibril polymorphism revealed by cryogenic electron microscopy of exon 1 HTT fibrils. J Am Chem Soc. 2022;144:10723\u201335.","journal-title":"J Am Chem Soc"},{"key":"651_CR57","doi-asserted-by":"crossref","unstructured":"Katsumoto A, Takeuchi H, Tanaka F. Tau pathology in chronic traumatic encephalopathy and Alzheimer\u2019s disease: similarities and differences. Front Neurol. 2019;10:1\u20139. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2019.00980.","DOI":"10.3389\/fneur.2019.00980"},{"key":"651_CR58","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","volume":"568","author":"B Falcon","year":"2019","unstructured":"Falcon B, Zivanov J, Zhang W, Murzin AG, Garringer HJ, Vidal R, et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature. 2019;568:420\u20133.","journal-title":"Nature"},{"key":"651_CR59","doi-asserted-by":"crossref","unstructured":"Metrick MA, Ferreira N do C, Saijo E, Kraus A, Newell K, Zanusso G, et al. A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases. Acta Neuropathol Commun. 2020;8:22.","DOI":"10.1186\/s40478-020-0887-z"},{"key":"651_CR60","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","volume":"561","author":"B Falcon","year":"2018","unstructured":"Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R, et al. Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold. Nature. 2018;561:137.","journal-title":"Nature"},{"key":"651_CR61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00401-019-02080-2","volume":"139","author":"E Saijo","year":"2020","unstructured":"Saijo E, Metrick MA, Koga S, Parchi P, Litvan I, Spina S, et al. 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration. Acta Neuropathol (Berl). 2020;139:63\u201377.","journal-title":"Acta Neuropathol (Berl)"},{"key":"651_CR62","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","volume":"580","author":"W Zhang","year":"2020","unstructured":"Zhang W, Tarutani A, Newell KL, Murzin AG, Matsubara T, Falcon B, et al. Novel tau filament fold in corticobasal degeneration. Nature. 2020;580:283\u20137.","journal-title":"Nature"},{"key":"651_CR63","doi-asserted-by":"publisher","first-page":"E8187","DOI":"10.1073\/pnas.1616344113","volume":"113","author":"AL Woerman","year":"2016","unstructured":"Woerman AL, Aoyagi A, Patel S, Kazmi SA, Lobach I, Grinberg LT, et al. Tau prions from Alzheimer\u2019s disease and chronic traumatic encephalopathy patients propagate in cultured cells. Proc Natl Acad Sci USA. 2016;113:E8187\u201396.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR64","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40478-019-0691-9","volume":"7","author":"DC Chung","year":"2019","unstructured":"Chung DC, Carlomagno Y, Cook CN, Jansen-West K, Daughrity L, Lewis-Tuffin LJ, et al. Tau exhibits unique seeding properties in globular glial tauopathy. Acta Neuropathol Commun. 2019;7:36.","journal-title":"Acta Neuropathol Commun"},{"key":"651_CR65","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136\u201344.","journal-title":"Science"},{"key":"651_CR66","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev.biochem.78.082907.145410","volume":"78","author":"B Caughey","year":"2009","unstructured":"Caughey B, Baron GS, Chesebro B, Jeffrey M. Getting a grip on prions: oligomers, amyloids and pathological membrane interactions. Annu Rev Biochem. 2009;78:177\u2013204.","journal-title":"Annu Rev Biochem"},{"key":"651_CR67","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1146\/annurev-pathmechdis-012418-013109","volume":"14","author":"CJ Sigurdson","year":"2019","unstructured":"Sigurdson CJ, Bartz JC, Glatzel M. Cellular and molecular mechanisms of prion disease. Annu Rev Pathol. 2019;14:497\u2013516.","journal-title":"Annu Rev Pathol"},{"key":"651_CR68","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41594-021-00565-x","volume":"28","author":"G Meisl","year":"2021","unstructured":"Meisl G, Kurt T, Condado-Morales I, Bett C, Sorce S, Nuvolone M, et al. Scaling analysis reveals the mechanism and rates of prion replication in vivo. Nat Struct Mol Biol. 2021;28:365\u201372.","journal-title":"Nat Struct Mol Biol"},{"key":"651_CR69","doi-asserted-by":"crossref","unstructured":"Wang L-Q, Zhao K, Yuan H-Y, Li X-N, Dang H-B, Ma Y, et al. Genetic prion disease\u2013related mutation E196K displays a novel amyloid fibril structure revealed by cryo-EM. Sci Adv. 2021;7:eabg9676.","DOI":"10.1126\/sciadv.abg9676"},{"key":"651_CR70","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1016\/j.molcel.2021.08.011","volume":"81","author":"A Kraus","year":"2021","unstructured":"Kraus A, Hoyt F, Schwartz CL, Hansen B, Artikis E, Hughson AG, et al. High-resolution structure and strain comparison of infectious mammalian prions. Mol Cell. 2021;81:4540\u20134551.e6.","journal-title":"Mol Cell"},{"key":"651_CR71","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41594-020-0441-5","volume":"27","author":"L-Q Wang","year":"2020","unstructured":"Wang L-Q, Zhao K, Yuan H-Y, Wang Q, Guan Z, Tao J, et al. Cryo-EM structure of an amyloid fibril formed by full-length human prion protein. Nat Struct Mol Biol. 2020;27:598\u2013602.","journal-title":"Nat Struct Mol Biol"},{"key":"651_CR72","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41594-020-0403-y","volume":"27","author":"C Glynn","year":"2020","unstructured":"Glynn C, Sawaya MR, Ge P, Gallagher-Jones M, Short CW, Bowman R, et al. Cryo-EM structure of a human prion fibril with a hydrophobic, protease-resistant core. Nat Struct Mol Biol. 2020;27:417\u201323.","journal-title":"Nat Struct Mol Biol"},{"key":"651_CR73","doi-asserted-by":"publisher","unstructured":"Manka SW, Wenborn A, Betts J, et al. A structural basis for prion strain diversity. Nat Chem Biol. 2023;19:607\u201313. https:\/\/doi.org\/10.1038\/s41589-022-01229-7.","DOI":"10.1038\/s41589-022-01229-7"},{"key":"651_CR74","doi-asserted-by":"crossref","unstructured":"Manka SW, Zhang W, Wenborn A, Betts J, Joiner S, Saibil HR, et al. 2.7 \u00c5 cryo-EM structure of ex vivo RML prion fibrils. Nat Commun. 2022;13:4004.","DOI":"10.1038\/s41467-022-30457-7"},{"key":"651_CR75","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1038\/s41467-022-30458-6","volume":"13","author":"F Hoyt","year":"2022","unstructured":"Hoyt F, Standke HG, Artikis E, Schwartz CL, Hansen B, Li K, et al. Cryo-EM structure of anchorless RML prion reveals variations in shared motifs between distinct strains. Nat Commun. 2022;13:4005.","journal-title":"Nat Commun"},{"key":"651_CR76","doi-asserted-by":"crossref","unstructured":"Kamali-Jamil R, V\u00e1zquez-Fern\u00e1ndez E, Tancowny B, Rathod V, Amidian S, Wang X, et al. The ultrastructure of infectious L-type bovine spongiform encephalopathy prions constrains molecular models. PLOS Pathog. 2021;17:e1009628.","DOI":"10.1371\/journal.ppat.1009628"},{"key":"651_CR77","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1038\/srep04267","volume":"4","author":"Y Bram","year":"2014","unstructured":"Bram Y, Frydman-Marom A, Yanai I, Gilead S, Shaltiel-Karyo R, Amdursky N, et al. Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies. Sci Rep. 2014;4:4267.","journal-title":"Sci Rep"},{"key":"651_CR78","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2353\/ajpath.2010.090532","volume":"176","author":"T Gurlo","year":"2010","unstructured":"Gurlo T, Ryazantsev S, Huang C, Yeh MW, Reber HA, Hines OJ, et al. Evidence for proteotoxicity in \u03b2 cells in Type 2 Diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am J Pathol. 2010;176:861\u20139.","journal-title":"Am J Pathol"},{"key":"651_CR79","doi-asserted-by":"crossref","unstructured":"Rodriguez Camargo DC, Chia S, Menzies J, Mannini B, Meisl G, Lundqvist M, et al. Surface-Catalyzed Secondary Nucleation Dominates the Generation of Toxic IAPP Aggregates. Front Mol Biosci. 2021;8:1\u201311. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fmolb.2021.757425.","DOI":"10.3389\/fmolb.2021.757425"},{"key":"651_CR80","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41594-020-0496-3","volume":"27","author":"R Gallardo","year":"2020","unstructured":"Gallardo R, Iadanza MG, Xu Y, Heath GR, Foster R, Radford SE, et al. Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly. Nat Struct Mol Biol. 2020;27:1048\u201356.","journal-title":"Nat Struct Mol Biol"},{"key":"651_CR81","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41594-020-0435-3","volume":"27","author":"Q Cao","year":"2020","unstructured":"Cao Q, Boyer DR, Sawaya MR, Ge P, Eisenberg DS. Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils. Nat Struct Mol Biol. 2020;27:653\u20139.","journal-title":"Nat Struct Mol Biol"},{"key":"651_CR82","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41594-021-00646-x","volume":"28","author":"Q Cao","year":"2021","unstructured":"Cao Q, Boyer DR, Sawaya MR, Abskharon R, Saelices L, Nguyen BA, et al. Cryo-EM structures of hIAPP fibrils seeded by patient-extracted fibrils reveal new polymorphs and conserved fibril cores. Nat Struct Mol Biol. 2021;28:724\u201330.","journal-title":"Nat Struct Mol Biol"},{"key":"651_CR83","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1074\/jbc.M308203200","volume":"279","author":"S Meehan","year":"2004","unstructured":"Meehan S, Berry Y, Luisi B, Dobson CM, Carver JA, MacPhee CE. Amyloid fibril formation by lens crystallin proteins and its implications for cataract formation. J Biol Chem. 2004;279:3413\u20139.","journal-title":"J Biol Chem"},{"key":"651_CR84","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12192-020-01098-w","volume":"25","author":"J Hayashi","year":"2020","unstructured":"Hayashi J, Carver JA. The multifaceted nature of \u03b1B-crystallin. Cell Stress Chaperones. 2020;25:639\u201354.","journal-title":"Cell Stress Chaperones"},{"key":"651_CR85","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41467-021-21129-z","volume":"12","author":"A Bansal","year":"2021","unstructured":"Bansal A, Schmidt M, Rennegarbe M, Haupt C, Liberta F, Stecher S, et al. AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils. Nat Commun. 2021;12:1013.","journal-title":"Nat Commun"},{"key":"651_CR86","doi-asserted-by":"publisher","first-page":"E6507","DOI":"10.1073\/pnas.1707120114","volume":"114","author":"S Jayaraman","year":"2017","unstructured":"Jayaraman S, Gantz DL, Haupt C, Gursky O. Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis. Proc Natl Acad Sci USA. 2017;114:E6507\u201315.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR87","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1016\/j.febslet.2009.04.026","volume":"583","author":"GT Westermark","year":"2009","unstructured":"Westermark GT, Westermark P. Serum amyloid A and protein AA: Molecular mechanisms of a transmissible amyloidosis. FEBS Lett. 2009;583:2685\u201390.","journal-title":"FEBS Lett"},{"key":"651_CR88","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41467-021-27688-5","volume":"13","author":"T Heerde","year":"2022","unstructured":"Heerde T, Rennegarbe M, Biedermann A, Savran D, Pfeiffer PB, Hitzenberger M, et al. Cryo-EM demonstrates the in vitro proliferation of an ex vivo amyloid fibril morphology by seeding. Nat Commun. 2022;13:85.","journal-title":"Nat Commun"},{"key":"651_CR89","doi-asserted-by":"publisher","first-page":"21998","DOI":"10.1074\/jbc.M602302200","volume":"281","author":"PF Teixeira","year":"2006","unstructured":"Teixeira PF, Cerca F, Santos SD, Saraiva MJ. Endoplasmic reticulum stress associated with extracellular aggregates: evidence from transthyretin deposition in familial amyloid polyneuropathy. J Biol Chem. 2006;281:21998\u20132003.","journal-title":"J Biol Chem"},{"key":"651_CR90","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0006-291X(02)00465-5","volume":"294","author":"K Andersson","year":"2002","unstructured":"Andersson K, Olofsson A, Nielsen EH, Svehag S-E, Lundgren E. Only amyloidogenic intermediates of transthyretin induce apoptosis. Biochem Biophys Res Commun. 2002;294:309\u201314.","journal-title":"Biochem Biophys Res Commun"},{"key":"651_CR91","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1073\/pnas.0400062101","volume":"101","author":"N Reixach","year":"2004","unstructured":"Reixach N, Deechongkit S, Jiang X, Kelly JW, Buxbaum JN. Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci USA. 2004;101:2817\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR92","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1038\/s41467-022-33591-4","volume":"13","author":"M Steinebrei","year":"2022","unstructured":"Steinebrei M, Gottwald J, Baur J, R\u00f6cken C, Hegenbart U, Sch\u00f6nland S, et al. Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis. Nat Commun. 2022;13:6398.","journal-title":"Nat Commun"},{"key":"651_CR93","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","volume":"10","author":"M Schmidt","year":"2019","unstructured":"Schmidt M, Wiese S, Adak V, Engler J, Agarwal S, Fritz G, et al. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis. Nat Commun. 2019;10:5008.","journal-title":"Nat Commun"},{"key":"651_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0034-3","volume":"4","author":"G Merlini","year":"2018","unstructured":"Merlini G, Dispenzieri A, Sanchorawala V, Sch\u00f6nland SO, Palladini G, Hawkins PN, et al. Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primer. 2018;4:1\u201319.","journal-title":"Nat Rev Dis Primer"},{"key":"651_CR95","doi-asserted-by":"crossref","unstructured":"Imperlini E, Gnecchi M, Rognoni P, Sabid\u00f2 E, Ciuffreda MC, Palladini G, et al. Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells. Sci Rep. 2017;7:15661.","DOI":"10.1038\/s41598-017-15424-3"},{"key":"651_CR96","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1021\/acs.biochem.6b00090","volume":"55","author":"LM Blancas-Mej\u00eda","year":"2016","unstructured":"Blancas-Mej\u00eda LM, Ramirez-Alvarado M. Recruitment of light chains by homologous and heterologous fibrils shows distinctive kinetic and conformational specificity. Biochemistry. 2016;55:2967\u201378.","journal-title":"Biochemistry"},{"key":"651_CR97","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41467-021-21126-2","volume":"12","author":"L Radamaker","year":"2021","unstructured":"Radamaker L, Baur J, Huhn S, Haupt C, Hegenbart U, Sch\u00f6nland S, et al. Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis. Nat Commun. 2021;12:875.","journal-title":"Nat Commun"},{"key":"651_CR98","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/s41467-019-09133-w","volume":"10","author":"P Swuec","year":"2019","unstructured":"Swuec P, Lavatelli F, Tasaki M, Paissoni C, Rognoni P, Maritan M, et al. Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient. Nat Commun. 2019;10:1269.","journal-title":"Nat Commun"},{"key":"651_CR99","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1021\/acs.biochem.2c00390","volume":"61","author":"AKR Dasari","year":"2022","unstructured":"Dasari AKR, Yi S, Coats MF, Wi S, Lim KH. Toxic Misfolded transthyretin oligomers with different molecular conformations formed through distinct oligomerization pathways. Biochemistry. 2022;61:2358\u201365.","journal-title":"Biochemistry"},{"key":"651_CR100","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chembiol.2012.02.003","volume":"19","author":"F Bemporad","year":"2012","unstructured":"Bemporad F, Chiti F. Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships. Chem Biol. 2012;19:315\u201327.","journal-title":"Chem Biol"},{"key":"651_CR101","doi-asserted-by":"publisher","first-page":"8651","DOI":"10.3390\/ijms21228651","volume":"21","author":"RP Kreiser","year":"2020","unstructured":"Kreiser RP, Wright AK, Block NR, Hollows JE, Nguyen LT, LeForte K, et al. Therapeutic strategies to reduce the toxicity of misfolded protein oligomers. Int J Mol Sci. 2020;21:8651.","journal-title":"Int J Mol Sci"},{"key":"651_CR102","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat Rev Mol Cell Biol. 2007;8:101\u201312.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"651_CR103","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova I, Karran E, De Strooper B. The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat Neurosci. 2012;15:349\u201357.","journal-title":"Nat Neurosci"},{"key":"651_CR104","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry. 2021;26:5481\u2013503.","journal-title":"Mol Psychiatry"},{"key":"651_CR105","doi-asserted-by":"publisher","first-page":"19813","DOI":"10.1074\/jbc.M116.736736","volume":"291","author":"M Marin-Argany","year":"2016","unstructured":"Marin-Argany M, Lin Y, Misra P, Williams A, Wall JS, Howell KG, et al. Cell damage in light chain amyloidosis. J Biol Chem. 2016;291:19813\u201325.","journal-title":"J Biol Chem"},{"key":"651_CR106","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1016\/j.bpj.2012.04.050","volume":"102","author":"L Pieri","year":"2012","unstructured":"Pieri L, Madiona K, Bousset L, Melki R. Fibrillar \u03b1-synuclein and huntingtin exon 1 assemblies are toxic to the cells. Biophys J. 2012;102:2894\u2013905.","journal-title":"Biophys J"},{"key":"651_CR107","doi-asserted-by":"crossref","unstructured":"Scheidt T, \u0141api\u0144ska U, Kumita JR, Whiten DR, Klenerman D, Wilson MR, et al. Secondary nucleation and elongation occur at different sites on Alzheimer\u2019s amyloid-\u03b2 aggregates. Sci Adv. 2019;5:eaau3112.","DOI":"10.1126\/sciadv.aau3112"},{"key":"651_CR108","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","volume":"12","author":"R Cascella","year":"2021","unstructured":"Cascella R, Chen SW, Bigi A, Camino JD, Xu CK, Dobson CM, et al. The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells. Nat Commun. 2021;12:1814.","journal-title":"Nat Commun"},{"key":"651_CR109","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/archneurol.2008.534","volume":"66","author":"KA Josephs","year":"2009","unstructured":"Josephs KA, Ahlskog JE, Parisi JE, Boeve BF, Crum BA, Giannini C, et al. Rapidly progressive neurodegenerative dementias. Arch Neurol. 2009;66:201\u20137.","journal-title":"Arch Neurol"},{"key":"651_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101644","volume":"180","author":"TW R\u00f6sler","year":"2019","unstructured":"R\u00f6sler TW, Tayaranian Marvian A, Brendel M, Nyk\u00e4nen N-P, H\u00f6llerhage M, Schwarz SC, et al. Four-repeat tauopathies. Prog Neurobiol. 2019;180: 101644.","journal-title":"Prog Neurobiol"},{"key":"651_CR111","doi-asserted-by":"crossref","unstructured":"Irwin DJ, Lee VM-Y, Trojanowski JQ. Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies. Nat Rev Neurosci. 2013;14:626\u201336.","DOI":"10.1038\/nrn3549"},{"key":"651_CR112","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9: a028035.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"651_CR113","doi-asserted-by":"publisher","first-page":"10245","DOI":"10.1073\/pnas.1807884115","volume":"115","author":"S Chia","year":"2018","unstructured":"Chia S, Habchi J, Michaels TCT, Cohen SIA, Linse S, Dobson CM, et al. SAR by kinetics for drug discovery in protein misfolding diseases. Proc Natl Acad Sci USA. 2018;115:10245\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR114","doi-asserted-by":"publisher","DOI":"10.1063\/5.0077609","volume":"156","author":"TCT Michaels","year":"2022","unstructured":"Michaels TCT, Dear AJ, Cohen SIA, Vendruscolo M, Knowles TPJ. Kinetic profiling of therapeutic strategies for inhibiting the formation of amyloid oligomers. J Chem Phys. 2022;156: 164904.","journal-title":"J Chem Phys"},{"key":"651_CR115","doi-asserted-by":"publisher","unstructured":"Kulenkampff K, Wolf Perez A-M, Sormanni P, Habchi J, Vendruscolo M. Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases. Nat Rev Chem.\u00a02021;5(4):277\u201394. https:\/\/doi.org\/10.1038\/s41570-021-00254-9.","DOI":"10.1038\/s41570-021-00254-9"},{"key":"651_CR116","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1021\/acs.accounts.3c00045","volume":"56","author":"R Limbocker","year":"2023","unstructured":"Limbocker R, Cremades N, Cascella R, Tessier PM, Vendruscolo M, Chiti F. Characterization of pairs of toxic and nontoxic misfolded protein oligomers elucidates the structural determinants of oligomer toxicity in protein misfolding diseases. Acc Chem Res. 2023;56:1395\u2013405.","journal-title":"Acc Chem Res"},{"key":"651_CR117","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann Neurol. 1999;46:860\u20136.","journal-title":"Ann Neurol"},{"key":"651_CR118","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486\u20139.","journal-title":"Science"},{"key":"651_CR119","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","volume":"27","author":"PN Lacor","year":"2007","unstructured":"Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease. J Neurosci. 2007;27:796\u2013807.","journal-title":"J Neurosci"},{"key":"651_CR120","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1326-2-18","volume":"2","author":"R Kayed","year":"2007","unstructured":"Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, Necula M, et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener. 2007;2:18.","journal-title":"Mol Neurodegener"},{"key":"651_CR121","doi-asserted-by":"publisher","first-page":"32895","DOI":"10.1074\/jbc.M109.000208","volume":"284","author":"A Noguchi","year":"2009","unstructured":"Noguchi A, Matsumura S, Dezawa M, Tada M, Yanazawa M, Ito A, et al. Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains. J Biol Chem. 2009;284:32895\u2013905.","journal-title":"J Biol Chem"},{"key":"651_CR122","doi-asserted-by":"publisher","first-page":"10369","DOI":"10.1523\/JNEUROSCI.5721-09.2010","volume":"30","author":"H Hillen","year":"2010","unstructured":"Hillen H, Barghorn S, Striebinger A, Labkovsky B, M\u00fcller R, Nimmrich V, et al. Generation and therapeutic efficacy of highly oligomer-specific \u03b2-amyloid antibodies. J Neurosci. 2010;30:10369\u201379.","journal-title":"J Neurosci"},{"key":"651_CR123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066381","volume":"8","author":"M H\u00f6ltt\u00e4","year":"2013","unstructured":"H\u00f6ltt\u00e4 M, Hansson O, Andreasson U, Hertze J, Minthon L, N\u00e4gga K, et al. Evaluating amyloid-\u03b2 oligomers in cerebrospinal fluid as a biomarker for Alzheimer\u2019s disease. PLoS ONE. 2013;8: e66381.","journal-title":"PLoS ONE"},{"key":"651_CR124","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1523\/JNEUROSCI.1675-13.2014","volume":"34","author":"MJ Savage","year":"2014","unstructured":"Savage MJ, Kalinina J, Wolfe A, Tugusheva K, Korn R, Cash-Mason T, et al. A sensitive a\u03b2 oligomer assay discriminates Alzheimer\u2019s and aged control cerebrospinal fluid. J Neurosci. 2014;34:2884\u201397.","journal-title":"J Neurosci"},{"key":"651_CR125","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/acn3.382","volume":"4","author":"U Sengupta","year":"2017","unstructured":"Sengupta U, Portelius E, Hansson O, Farmer K, Castillo-Carranza D, Woltjer R, et al. Tau oligomers in cerebrospinal fluid in Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2017;4:226\u201335.","journal-title":"Ann Clin Transl Neurol"},{"key":"651_CR126","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1073\/pnas.1910444117","volume":"117","author":"G Vecchi","year":"2020","unstructured":"Vecchi G, Sormanni P, Mannini B, Vandelli A, Tartaglia GG, Dobson CM, et al. Proteome-wide observation of the phenomenon of life on the edge of solubility. Proc Natl Acad Sci USA. 2020;117:1015\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR127","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.tibs.2007.03.005","volume":"32","author":"GG Tartaglia","year":"2007","unstructured":"Tartaglia GG, Pechmann S, Dobson CM, Vendruscolo M. Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci. 2007;32:204\u20136.","journal-title":"Trends Biochem Sci"},{"key":"651_CR128","doi-asserted-by":"publisher","first-page":"14160","DOI":"10.1021\/ja2017703","volume":"133","author":"AJ Baldwin","year":"2011","unstructured":"Baldwin AJ, Knowles TPJ, Tartaglia GG, Fitzpatrick AW, Devlin GL, Shammas SL, et al. Metastability of native proteins and the phenomenon of amyloid formation. J Am Chem Soc. 2011;133:14160\u20133.","journal-title":"J Am Chem Soc"},{"key":"651_CR129","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","volume":"148","author":"D Eisenberg","year":"2012","unstructured":"Eisenberg D, Jucker M. The amyloid state of proteins in human diseases. Cell. 2012;148:1188\u2013203.","journal-title":"Cell"},{"key":"651_CR130","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1006\/jmbi.1997.1348","volume":"273","author":"M Sunde","year":"1997","unstructured":"Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, Blake CCF. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol. 1997;273:729\u201339.","journal-title":"J Mol Biol"},{"key":"651_CR131","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0968-0004(99)01445-0","volume":"24","author":"CM Dobson","year":"1999","unstructured":"Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci. 1999;24:329\u201332.","journal-title":"Trends Biochem Sci"},{"key":"651_CR132","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41556-021-00697-8","volume":"23","author":"M Fuxreiter","year":"2021","unstructured":"Fuxreiter M, Vendruscolo M. Generic nature of the condensed states of proteins. Nat Cell Biol. 2021;23:587\u201394.","journal-title":"Nat Cell Biol"},{"key":"651_CR133","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/d41586-020-00341-9","volume":"578","author":"E Callaway","year":"2020","unstructured":"Callaway E. Revolutionary cryo-EM is taking over structural biology. Nature. 2020;578:201.","journal-title":"Nature"},{"key":"651_CR134","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SHW Scheres","year":"2012","unstructured":"Scheres SHW. RELION: Implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol. 2012;180:519\u201330.","journal-title":"J Struct Biol"},{"key":"651_CR135","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.sbi.2020.05.011","volume":"64","author":"SH Scheres","year":"2020","unstructured":"Scheres SH, Zhang W, Falcon B, Goedert M. Cryo-EM structures of tau filaments. Curr Opin Struct Biol. 2020;64:17\u201325.","journal-title":"Curr Opin Struct Biol"},{"key":"651_CR136","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-021-04199-3","volume":"601","author":"D Arseni","year":"2022","unstructured":"Arseni D, Hasegawa M, Murzin AG, Kametani F, Arai M, Yoshida M, et al. Structure of pathological TDP-43 filaments from ALS with FTLD. Nature. 2022;601:139\u201343.","journal-title":"Nature"},{"key":"651_CR137","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1016\/j.cell.2021.08.013","volume":"184","author":"MR Sawaya","year":"2021","unstructured":"Sawaya MR, Hughes MP, Rodriguez JA, Riek R, Eisenberg DS. The expanding amyloid family: Structure, stability, function, and pathogenesis. Cell. 2021;184:4857\u201373.","journal-title":"Cell"},{"key":"651_CR138","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2013.08.035","volume":"154","author":"J-X Lu","year":"2013","unstructured":"Lu J-X, Qiang W, Yau W-M, Schwieters CD, Meredith SC, Tycko R. Molecular structure of \u03b2-amyloid fibrils in Alzheimer\u2019s disease brain tissue. Cell. 2013;154:1257\u201368.","journal-title":"Cell"},{"key":"651_CR139","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature20814","volume":"541","author":"W Qiang","year":"2017","unstructured":"Qiang W, Yau W-M, Lu J-X, Collinge J, Tycko R. Structural variation in amyloid-\u03b2 fibrils from Alzheimer\u2019s disease clinical subtypes. Nature. 2017;541:217\u201321.","journal-title":"Nature"},{"key":"651_CR140","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature10317","volume":"475","author":"FU Hartl","year":"2011","unstructured":"Hartl FU, Bracher A, Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature. 2011;475:324\u201332.","journal-title":"Nature"},{"key":"651_CR141","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1126\/science.1150057","volume":"318","author":"TP Knowles","year":"2007","unstructured":"Knowles TP, Fitzpatrick AW, Meehan S, Mott HR, Vendruscolo M, Dobson CM, et al. Role of intermolecular forces in defining material properties of protein nanofibrils. Science. 2007;318:1900\u20133.","journal-title":"Science"},{"key":"651_CR142","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tibs.2007.03.003","volume":"32","author":"DM Fowler","year":"2007","unstructured":"Fowler DM, Koulov AV, Balch WE, Kelly JW. Functional amyloid \u2013 from bacteria to humans. Trends Biochem Sci. 2007;32:217\u201324.","journal-title":"Trends Biochem Sci"},{"key":"651_CR143","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a033860","volume":"11","author":"D Otzen","year":"2019","unstructured":"Otzen D, Riek R. Functional Amyloids. Cold Spring Harb Perspect Biol. 2019;11: a033860.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"651_CR144","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1126\/science.aba3526","volume":"367","author":"R Hervas","year":"2020","unstructured":"Hervas R, Rau MJ, Park Y, Zhang W, Murzin AG, Fitzpatrick JAJ, et al. Cryo-EM structure of a neuronal functional amyloid implicated in memory persistence in Drosophila. Science. 2020;367:1230\u20134.","journal-title":"Science"},{"key":"651_CR145","doi-asserted-by":"crossref","unstructured":"Meisl G, Xu CK, Taylor JD, Michaels TCT, Levin A, Otzen D, et al. Uncovering the universality of self-replication in protein aggregation and its link to disease. Sci Adv. 2022;8:eabn6831.","DOI":"10.1126\/sciadv.abn6831"},{"key":"651_CR146","doi-asserted-by":"publisher","first-page":"15902","DOI":"10.1038\/ncomms15902","volume":"8","author":"U Shimanovich","year":"2017","unstructured":"Shimanovich U, Ruggeri FS, Genst ED, Adamcik J, Barros TP, Porter D, et al. Silk micrococoons for protein stabilisation and molecular encapsulation. Nat Commun. 2017;8:15902.","journal-title":"Nat Commun"},{"key":"651_CR147","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nnano.2015.310","volume":"11","author":"S Bolisetty","year":"2016","unstructured":"Bolisetty S, Mezzenga R. Amyloid\u2013carbon hybrid membranes for universal water purification. Nat Nanotechnol. 2016;11:365\u201371.","journal-title":"Nat Nanotechnol"},{"key":"651_CR148","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1021\/acschemneuro.2c00799","volume":"14","author":"I Horvath","year":"2023","unstructured":"Horvath I, Wittung-Stafshede P. Amyloid fibers of \u03b1-synuclein catalyze chemical reactions. ACS Chem Neurosci. 2023;14:603\u20138.","journal-title":"ACS Chem Neurosci"},{"key":"651_CR149","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.checat.2021.07.005","volume":"1","author":"E Arad","year":"2021","unstructured":"Arad E, Baruch Leshem A, Rapaport H, Jelinek R. \u03b2-Amyloid fibrils catalyze neurotransmitter degradation. Chem Catal. 2021;1:908\u201322.","journal-title":"Chem Catal"},{"key":"651_CR150","doi-asserted-by":"crossref","unstructured":"Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem. 1997;272:22364\u201372.","DOI":"10.1074\/jbc.272.35.22364"},{"key":"651_CR151","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1074-5521(97)90255-6","volume":"4","author":"JD Harper","year":"1997","unstructured":"Harper JD, Wong SS, Lieber CM, Lansbury PT. Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem Biol. 1997;4:119\u201325.","journal-title":"Chem Biol"},{"key":"651_CR152","doi-asserted-by":"publisher","first-page":"9564","DOI":"10.1074\/jbc.270.16.9564","volume":"270","author":"MB Podlisny","year":"1995","unstructured":"Podlisny MB, Ostaszewski BL, Squazzo SL, Koo EH, Rydell RE, Teplow DB, et al. Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem. 1995;270:9564\u201370.","journal-title":"J Biol Chem"},{"key":"651_CR153","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nsmb.1799","volume":"17","author":"M Ahmed","year":"2010","unstructured":"Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S, et al. Structural conversion of neurotoxic amyloid-\u03b21-42 oligomers to fibrils. Nat Struct Mol Biol. 2010;17:561\u20137.","journal-title":"Nat Struct Mol Biol"},{"key":"651_CR154","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nsmb1345","volume":"14","author":"S Chimon","year":"2007","unstructured":"Chimon S, Shaibat MA, Jones CR, Calero DC, Aizezi B, Ishii Y. Evidence of fibril-like \u03b2-sheet structures in a neurotoxic amyloid intermediate of Alzheimer\u2019s \u03b2-amyloid. Nat Struct Mol Biol. 2007;14:1157\u201364.","journal-title":"Nat Struct Mol Biol"},{"key":"651_CR155","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1073\/pnas.1237107100","volume":"100","author":"M Hoshi","year":"2003","unstructured":"Hoshi M, Sato M, Matsumoto S, Noguchi A, Yasutake K, Yoshida N, et al. Spherical aggregates of \u03b2-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I\/glycogen synthase kinase-3\u03b2. Proc Natl Acad Sci USA. 2003;100:6370\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR156","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/j.1471-4159.2005.03407.x","volume":"95","author":"S Barghorn","year":"2005","unstructured":"Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, Janson B, et al. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer\u2019s disease. J Neurochem. 2005;95:834\u201347.","journal-title":"J Neurochem"},{"key":"651_CR157","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1074\/jbc.M808591200","volume":"284","author":"R Kayed","year":"2009","unstructured":"Kayed R, Pensalfini A, Margol L, Sokolov Y, Sarsoza F, Head E, et al. Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem. 2009;284:4230\u20137.","journal-title":"J Biol Chem"},{"key":"651_CR158","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, et al. Diffusible, nonfibrillar ligands derived from A\u03b21\u201342 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA. 1998;95:6448\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR159","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1073\/pnas.222681699","volume":"100","author":"G Bitan","year":"2003","unstructured":"Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB. Amyloid \u03b2-protein (A\u03b2) assembly: A\u03b240 and A\u03b242 oligomerize through distinct pathways. Proc Natl Acad Sci USA. 2003;100:330\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR160","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades N, Cohen SIA, Deas E, Abramov AY, Chen AY, Orte A, et al. Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein. Cell. 2012;149:1048\u201359.","journal-title":"Cell"},{"key":"651_CR161","first-page":"E1994","volume":"112","author":"SW Chen","year":"2015","unstructured":"Chen SW, Drakulic S, Deas E, Ouberai M, Aprile FA, Arranz R, et al. Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation. Proc Natl Acad Sci USA. 2015;112:E1994\u20132003.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR162","doi-asserted-by":"publisher","first-page":"26733","DOI":"10.1074\/jbc.M114.566695","volume":"289","author":"JI Gallea","year":"2014","unstructured":"Gallea JI, Celej MS. Structural insights into amyloid oligomers of the Parkinson disease-related protein \u03b1-synuclein. J Biol Chem. 2014;289:26733\u201342.","journal-title":"J Biol Chem"},{"key":"651_CR163","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1021\/ja411577t","volume":"136","author":"N Lorenzen","year":"2014","unstructured":"Lorenzen N, Nielsen SB, Buell AK, Kaspersen JD, Arosio P, Vad BS, et al. The role of stable \u03b1-Synuclein oligomers in the molecular events underlying amyloid formation. J Am Chem Soc. 2014;136:3859\u201368.","journal-title":"J Am Chem Soc"},{"key":"651_CR164","doi-asserted-by":"publisher","first-page":"7717","DOI":"10.1073\/pnas.1203193109","volume":"109","author":"JC Stroud","year":"2012","unstructured":"Stroud JC, Liu C, Teng PK, Eisenberg D. Toxic fibrillar oligomers of amyloid-\u03b2 have cross-\u03b2 structure. Proc Natl Acad Sci USA. 2012;109:7717\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR165","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1021\/jacs.5b03373","volume":"137","author":"S Parthasarathy","year":"2015","unstructured":"Parthasarathy S, Inoue M, Xiao Y, Matsumura Y, Nabeshima Y, Hoshi M, et al. Structural insight into an alzheimer\u2019s brain-derived spherical assembly of amyloid \u03b2 by solid-state NMR. J Am Chem Soc. 2015;137:6480\u20133.","journal-title":"J Am Chem Soc"},{"key":"651_CR166","doi-asserted-by":"publisher","first-page":"14411","DOI":"10.1523\/JNEUROSCI.3537-10.2010","volume":"30","author":"B O\u2019Nuallain","year":"2010","unstructured":"O\u2019Nuallain B, Freir DB, Nicoll AJ, Risse E, Ferguson N, Herron CE, et al. Amyloid \u03b2-protein dimers rapidly form stable synaptotoxic protofibrils. J Neurosci. 2010;30:14411\u20139.","journal-title":"J Neurosci"},{"key":"651_CR167","doi-asserted-by":"publisher","first-page":"7828","DOI":"10.1073\/pnas.0812227106","volume":"106","author":"N Carulla","year":"2009","unstructured":"Carulla N, Zhou M, Arimon M, Gair\u00ed M, Giralt E, Robinson CV, et al. Experimental characterization of disordered and ordered aggregates populated during the process of amyloid fibril formation. Proc Natl Acad Sci USA. 2009;106:7828\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR168","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0022-2836(02)01175-0","volume":"325","author":"AJ Modler","year":"2003","unstructured":"Modler AJ, Gast K, Lutsch G, Damaschun G. Assembly of amyloid protofibrils via critical oligomers\u2013a novel pathway of amyloid formation. J Mol Biol. 2003;325:135\u201348.","journal-title":"J Mol Biol"},{"key":"651_CR169","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1110\/ps.9.10.1960","volume":"9","author":"M Bouchard","year":"2000","unstructured":"Bouchard M, Zurdo J, Nettleton EJ, Dobson CM, Robinson CV. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci Publ Protein Soc. 2000;9:1960\u20137.","journal-title":"Protein Sci Publ Protein Soc"},{"key":"651_CR170","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jmb.2005.06.043","volume":"351","author":"G Plakoutsi","year":"2005","unstructured":"Plakoutsi G, Bemporad F, Calamai M, Taddei N, Dobson CM, Chiti F. Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. J Mol Biol. 2005;351:910\u201322.","journal-title":"J Mol Biol"},{"key":"651_CR171","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.1074\/jbc.M110.181313","volume":"286","author":"S Matsumura","year":"2011","unstructured":"Matsumura S, Shinoda K, Yamada M, Yokojima S, Inoue M, Ohnishi T, et al. Two distinct amyloid \u03b2-protein (a\u03b2) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses. J Biol Chem. 2011;286:11555\u201362.","journal-title":"J Biol Chem"},{"key":"651_CR172","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1021\/acs.biochem.5b00467","volume":"54","author":"Z Fu","year":"2015","unstructured":"Fu Z, Aucoin D, Davis J, Van Nostrand WE, Smith SO. Mechanism of nucleated conformational conversion of A\u03b242. Biochemistry. 2015;54:4197\u2013207.","journal-title":"Biochemistry"},{"key":"651_CR173","doi-asserted-by":"publisher","first-page":"22122","DOI":"10.1074\/jbc.M111.236257","volume":"286","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves CA, Glabe CG, Kayed R. Amyloid-\u03b2 annular protofibrils evade fibrillar fate in Alzheimer disease brain. J Biol Chem. 2011;286:22122\u201330.","journal-title":"J Biol Chem"},{"key":"651_CR174","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41557-020-0452-1","volume":"12","author":"TCT Michaels","year":"2020","unstructured":"Michaels TCT, \u0160ari\u0107 A, Curk S, Bernfur K, Arosio P, Meisl G, et al. Dynamics of oligomer populations formed during the aggregation of Alzheimer\u2019s A\u03b242 peptide. Nat Chem. 2020;12:445\u201351.","journal-title":"Nat Chem"},{"key":"651_CR175","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jmb.2012.02.031","volume":"421","author":"SIA Cohen","year":"2012","unstructured":"Cohen SIA, Vendruscolo M, Dobson CM, Knowles TPJ. From macroscopic measurements to microscopic mechanisms of protein aggregation. J Mol Biol. 2012;421:160\u201371.","journal-title":"J Mol Biol"},{"key":"651_CR176","doi-asserted-by":"crossref","unstructured":"Lee VM-Y. Amyloid binding ligands as Alzheimer\u2019s disease therapies. Neurobiol Aging. 2002;23:1039\u201342.","DOI":"10.1016\/S0197-4580(02)00121-5"},{"key":"651_CR177","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","volume":"1804","author":"M Biancalana","year":"2010","unstructured":"Biancalana M, Koide S. Molecular mechanism of thioflavin-t binding to amyloid fibrils. Biochim Biophys Acta. 2010;1804:1405\u201312.","journal-title":"Biochim Biophys Acta"},{"key":"651_CR178","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0076-6879(99)09019-9","volume":"309","author":"F Ferrone","year":"1999","unstructured":"Ferrone F. Analysis of protein aggregation kinetics. Methods Enzymol. 1999;309:256\u201374.","journal-title":"Methods Enzymol"},{"key":"651_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42004-020-00412-y","volume":"3","author":"R Staats","year":"2020","unstructured":"Staats R, Michaels TCT, Flagmeier P, Chia S, Horne RI, Habchi J, et al. Screening of small molecules using the inhibition of oligomer formation in \u03b1-synuclein aggregation as a selection parameter. Commun Chem. 2020;3:1\u20139.","journal-title":"Commun Chem"},{"key":"651_CR180","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1126\/science.1178250","volume":"326","author":"TPJ Knowles","year":"2009","unstructured":"Knowles TPJ, Waudby CA, Devlin GL, Cohen SIA, Aguzzi A, Vendruscolo M, et al. An Analytical solution to the kinetics of breakable filament assembly. Science. 2009;326:1533\u20137.","journal-title":"Science"},{"key":"651_CR181","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nprot.2016.010","volume":"11","author":"G Meisl","year":"2016","unstructured":"Meisl G, Kirkegaard JB, Arosio P, Michaels TCT, Vendruscolo M, Dobson CM, et al. Molecular mechanisms of protein aggregation from global fitting of kinetic models. Nat Protoc. 2016;11:252\u201372.","journal-title":"Nat Protoc"},{"key":"651_CR182","doi-asserted-by":"crossref","unstructured":"Cohen SIA, Vendruscolo M, Welland ME, Dobson CM, Terentjev EM, Knowles TPJ. Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. J Chem Phys. 2011;135:065105.","DOI":"10.1063\/1.3608916"},{"key":"651_CR183","doi-asserted-by":"crossref","unstructured":"Cohen SIA, Vendruscolo M, Dobson CM, Knowles TPJ. Nucleated polymerization with secondary pathways II. Determination of self-consistent solutions to growth processes described by non-linear master equations. J Chem Phys. 2011;135:065106.","DOI":"10.1063\/1.3608917"},{"key":"651_CR184","doi-asserted-by":"crossref","unstructured":"Cohen SIA, Vendruscolo M, Dobson CM, Knowles TPJ. Nucleated polymerization with secondary pathways III. Equilibrium behavior and oligomer populations. J Chem Phys. 2011;135:065107.","DOI":"10.1063\/1.3608918"},{"key":"651_CR185","doi-asserted-by":"crossref","unstructured":"Meisl G, Rajah L, I.\u00a0Cohen SA, Pfammatter M, \u0160ari\u0107 A, Hellstrand E, et al. Scaling behaviour and rate-determining steps in filamentous self-assembly. Chem Sci. 2017;8:7087\u201397.","DOI":"10.1039\/C7SC01965C"},{"key":"651_CR186","doi-asserted-by":"publisher","first-page":"12087","DOI":"10.1073\/pnas.1922267117","volume":"117","author":"AJ Dear","year":"2020","unstructured":"Dear AJ, Michaels TCT, Meisl G, Klenerman D, Wu S, Perrett S, et al. Kinetic diversity of amyloid oligomers. Proc Natl Acad Sci USA. 2020;117:12087\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR187","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1042\/BCJ20160868","volume":"476","author":"AK Buell","year":"2019","unstructured":"Buell AK. The growth of amyloid fibrils: rates and mechanisms. Biochem J. 2019;476:2677\u2013703.","journal-title":"Biochem J"},{"key":"651_CR188","doi-asserted-by":"publisher","first-page":"27987","DOI":"10.1039\/C7CP03412A","volume":"19","author":"LJ Young","year":"2017","unstructured":"Young LJ, Schierle GSK, Kaminski CF. Imaging A\u03b2(1\u201342) fibril elongation reveals strongly polarised growth and growth incompetent states. Phys Chem Chem Phys. 2017;19:27987\u201396.","journal-title":"Phys Chem Chem Phys"},{"key":"651_CR189","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41557-018-0031-x","volume":"10","author":"J Habchi","year":"2018","unstructured":"Habchi J, Chia S, Galvagnion C, Michaels TCT, Bellaiche MMJ, Ruggeri FS, et al. Cholesterol catalyses A\u03b242 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes. Nat Chem. 2018;10:673\u201383.","journal-title":"Nat Chem"},{"key":"651_CR190","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nchembio.1750","volume":"11","author":"C Galvagnion","year":"2015","unstructured":"Galvagnion C, Buell AK, Meisl G, Michaels TCT, Vendruscolo M, Knowles TPJ, et al. Lipid vesicles trigger \u03b1-synuclein aggregation by stimulating primary nucleation. Nat Chem Biol. 2015;11:229\u201334.","journal-title":"Nat Chem Biol"},{"key":"651_CR191","doi-asserted-by":"publisher","first-page":"14746","DOI":"10.1073\/pnas.1105555108","volume":"108","author":"TPJ Knowles","year":"2011","unstructured":"Knowles TPJ, White DA, Abate AR, Agresti JJ, Cohen SIA, Sperling RA, et al. Observation of spatial propagation of amyloid assembly from single nuclei. Proc Natl Acad Sci USA. 2011;108:14746\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR192","doi-asserted-by":"crossref","unstructured":"T\u00f6rnquist M, T.\u00a0Michaels TC, Sanagavarapu K, Yang X, Meisl G, A.\u00a0Cohen SI, et al. Secondary nucleation in amyloid formation. Chem Commun. 2018;54:8667\u201384.","DOI":"10.1039\/C8CC02204F"},{"key":"651_CR193","doi-asserted-by":"publisher","unstructured":"Botsaris GD. Secondary nucleation \u2014 a review. In: Mullin JW. (eds) Industrial crystallization. Boston: Springer; 1976. https:\/\/doi.org\/10.1007\/978-1-4615-7258-9_1.","DOI":"10.1007\/978-1-4615-7258-9_1"},{"key":"651_CR194","doi-asserted-by":"crossref","unstructured":"Ferrone FA, Hofrichter J, Eaton WA. Kinetics of sickle hemoglobin polymerization: II. A double nucleation mechanism. J Mol Biol. 1985;183:611\u201331.","DOI":"10.1016\/0022-2836(85)90175-5"},{"key":"651_CR195","doi-asserted-by":"publisher","first-page":"12341","DOI":"10.1073\/pnas.0703306104","volume":"104","author":"AM Ruschak","year":"2007","unstructured":"Ruschak AM, Miranker AD. Fiber-dependent amyloid formation as catalysis of an existing reaction pathway. Proc Natl Acad Sci USA. 2007;104:12341\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR196","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1021\/jp710131u","volume":"112","author":"V Foder\u00e0","year":"2008","unstructured":"Foder\u00e0 V, Librizzi F, Groenning M, van de Weert M, Leone M. Secondary nucleation and accessible surface in insulin amyloid fibril formation. J Phys Chem B. 2008;112:3853\u20138.","journal-title":"J Phys Chem B"},{"key":"651_CR197","doi-asserted-by":"crossref","unstructured":"Gaspar R, Meisl G, Buell AK, Young L, Kaminski CF, Knowles TPJ, et al. Secondary nucleation of monomers on fibril surface dominates \u03b1-synuclein aggregation and provides autocatalytic amyloid amplification. Q Rev Biophys. 2017;50:1\u201312. Available from: https:\/\/www.cambridge.org\/core\/journals\/quarterly-reviews-of-biophysics\/article\/secondary-nucleation-of-monomers-on-fibril-surface-dominates-synuclein-aggregation-and-provides-autocatalytic-amyloid-amplification\/36C9559FB74EE301AC7440C31A2E6151.","DOI":"10.1017\/S0033583516000172"},{"key":"651_CR198","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220664120","volume":"120","author":"D Thacker","year":"2023","unstructured":"Thacker D, Barghouth M, Bless M, Zhang E, Linse S. Direct observation of secondary nucleation along the fibril surface of the amyloid \u03b2 42 peptide. Proc Natl Acad Sci USA. 2023;120: e2220664120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR199","doi-asserted-by":"publisher","first-page":"16621","DOI":"10.1021\/jacs.1c07228","volume":"143","author":"MR Zimmermann","year":"2021","unstructured":"Zimmermann MR, Bera SC, Meisl G, Dasadhikari S, Ghosh S, Linse S, et al. Mechanism of secondary nucleation at the single fibril level from direct observations of A\u03b242 aggregation. J Am Chem Soc. 2021;143:16621\u20139.","journal-title":"J Am Chem Soc"},{"key":"651_CR200","doi-asserted-by":"publisher","first-page":"8585","DOI":"10.1074\/jbc.M110.172411","volume":"286","author":"A Jan","year":"2011","unstructured":"Jan A, Adolfsson O, Allaman I, Buccarello A-L, Magistretti PJ, Pfeifer A, et al. Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species. J Biol Chem. 2011;286:8585\u201396.","journal-title":"J Biol Chem"},{"key":"651_CR201","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1021\/bm0505078","volume":"7","author":"EK Hill","year":"2006","unstructured":"Hill EK, Krebs B, Goodall DG, Howlett GJ, Dunstan DE. Shear flow induces amyloid fibril formation. Biomacromol. 2006;7:10\u20133.","journal-title":"Biomacromol"},{"key":"651_CR202","doi-asserted-by":"publisher","first-page":"8926","DOI":"10.1073\/pnas.0711664105","volume":"105","author":"W-F Xue","year":"2008","unstructured":"Xue W-F, Homans SW, Radford SE. Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc Natl Acad Sci USA. 2008;105:8926\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR203","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002522","volume":"8","author":"C Bett","year":"2012","unstructured":"Bett C, Joshi-Barr S, Lucero M, Trejo M, Liberski P, Kelly JW, et al. Biochemical properties of highly neuroinvasive prion strains. PLOS Pathog. 2012;8: e1002522.","journal-title":"PLOS Pathog"},{"key":"651_CR204","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1021\/acschemneuro.8b00094","volume":"9","author":"F Kundel","year":"2018","unstructured":"Kundel F, Hong L, Falcon B, McEwan WA, Michaels TCT, Meisl G, et al. Measurement of tau filament fragmentation provides insights into prion-like spreading. ACS Chem Neurosci. 2018;9:1276\u201382.","journal-title":"ACS Chem Neurosci"},{"key":"651_CR205","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1126\/science.1098007","volume":"304","author":"J Shorter","year":"2004","unstructured":"Shorter J, Lindquist S. Hsp104 catalyzes formation and elimination of self-replicating sup35 prion conformers. Science. 2004;304:1793\u20137.","journal-title":"Science"},{"key":"651_CR206","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00401-018-1947-3","volume":"137","author":"A Kraus","year":"2019","unstructured":"Kraus A, Saijo E, Metrick MA, Newell K, Sigurdson CJ, Zanusso G, et al. Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease. Acta Neuropathol (Berl). 2019;137:585\u201398.","journal-title":"Acta Neuropathol (Berl)"},{"key":"651_CR207","doi-asserted-by":"publisher","unstructured":"Saijo E, Groveman BR, Kraus A, Metrick M, Orr\u00f9 CD, Hughson AG, et al. Ultrasensitive RT-QuIC seed amplification assays for disease-associated tau, \u03b1-synuclein, and prion aggregates. Protein Misfolding Dis Methods Protoc. 2019:19\u201337. https:\/\/doi.org\/10.1007\/978-1-4939-8820-4_2.","DOI":"10.1007\/978-1-4939-8820-4_2"},{"key":"651_CR208","doi-asserted-by":"publisher","first-page":"34272","DOI":"10.1074\/jbc.M109.049809","volume":"284","author":"W-F Xue","year":"2009","unstructured":"Xue W-F, Hellewell AL, Gosal WS, Homans SW, Hewitt EW, Radford SE. Fibril fragmentation enhances amyloid cytotoxicity. J Biol Chem. 2009;284:34272\u201382.","journal-title":"J Biol Chem"},{"key":"651_CR209","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"106","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA. 2009;106:4012\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR210","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1021\/acschemneuro.9b00562","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wes\u00e9n E, Kumar R, Bernson D, Gallud A, Paul A, et al. Correlation between cellular uptake and cytotoxicity of fragmented \u03b1-synuclein amyloid fibrils suggests intracellular basis for toxicity. ACS Chem Neurosci. 2020;11:233\u201341.","journal-title":"ACS Chem Neurosci"},{"key":"651_CR211","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40478-017-0430-z","volume":"5","author":"C Bett","year":"2017","unstructured":"Bett C, Lawrence J, Kurt TD, Orru C, Aguilar-Calvo P, Kincaid AE, et al. Enhanced neuroinvasion by smaller, soluble prions. Acta Neuropathol Commun. 2017;5:32.","journal-title":"Acta Neuropathol Commun"},{"key":"651_CR212","doi-asserted-by":"publisher","DOI":"10.1063\/1.4927655","volume":"143","author":"TCT Michaels","year":"2015","unstructured":"Michaels TCT, Lazell HW, Arosio P, Knowles TPJ. Dynamics of protein aggregation and oligomer formation governed by secondary nucleation. J Chem Phys. 2015;143: 054901.","journal-title":"J Chem Phys"},{"key":"651_CR213","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1021\/jacs.7b10439","volume":"140","author":"J Yang","year":"2018","unstructured":"Yang J, Dear AJ, Michaels TCT, Dobson CM, Knowles TPJ, Wu S, et al. Direct observation of oligomerization by single molecule fluorescence reveals a multistep aggregation mechanism for the yeast prion protein Ure2. J Am Chem Soc. 2018;140:2493\u2013503.","journal-title":"J Am Chem Soc"},{"key":"651_CR214","doi-asserted-by":"publisher","first-page":"E1206","DOI":"10.1073\/pnas.1524128113","volume":"113","author":"M Iljina","year":"2016","unstructured":"Iljina M, Garcia GA, Horrocks MH, Tosatto L, Choi ML, Ganzinger KA, et al. Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading. Proc Natl Acad Sci USA. 2016;113:E1206\u201315.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR215","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1016\/j.jmb.2020.03.004","volume":"432","author":"WM Babinchak","year":"2020","unstructured":"Babinchak WM, Surewicz WK. Liquid\u2013liquid phase separation and its mechanistic role in pathological protein aggregation. J Mol Biol. 2020;432:1910\u201325.","journal-title":"J Mol Biol"},{"key":"651_CR216","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2018.12.035","volume":"176","author":"S Alberti","year":"2019","unstructured":"Alberti S, Gladfelter A, Mittag T. Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates. Cell. 2019;176:419\u201334.","journal-title":"Cell"},{"key":"651_CR217","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrm.2017.7","volume":"18","author":"SF Banani","year":"2017","unstructured":"Banani SF, Lee HO, Hyman AA, Rosen MK. Biomolecular condensates: organizers of cellular biochemistry. Nat Rev Mol Cell Biol. 2017;18:285\u201398.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"651_CR218","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41573-022-00505-4","volume":"21","author":"DM Mitrea","year":"2022","unstructured":"Mitrea DM, Mittasch M, Gomes BF, Klein IA, Murcko MA. Modulating biomolecular condensates: a novel approach to drug discovery. Nat Rev Drug Discov. 2022;21:841\u201362.","journal-title":"Nat Rev Drug Discov"},{"key":"651_CR219","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1038\/s41467-022-32940-7","volume":"13","author":"M Vendruscolo","year":"2022","unstructured":"Vendruscolo M, Fuxreiter M. Protein condensation diseases: therapeutic opportunities. Nat Commun. 2022;13:5550.","journal-title":"Nat Commun"},{"key":"651_CR220","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.3390\/ijms22063017","volume":"22","author":"N Farahi","year":"2021","unstructured":"Farahi N, Lazar T, Wodak SJ, Tompa P, Pancsa R. Integration of data from liquid\u2013liquid phase separation databases highlights concentration and dosage sensitivity of LLPS drivers. Int J Mol Sci. 2021;22:3017.","journal-title":"Int J Mol Sci"},{"key":"651_CR221","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s41467-021-21181-9","volume":"12","author":"G Krainer","year":"2021","unstructured":"Krainer G, Welsh TJ, Joseph JA, Espinosa JR, Wittmann S, de Csill\u00e9ry E, et al. Reentrant liquid condensate phase of proteins is stabilized by hydrophobic and non-ionic interactions. Nat Commun. 2021;12:1085.","journal-title":"Nat Commun"},{"key":"651_CR222","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1021\/acs.biochem.8b00008","volume":"57","author":"EW Martin","year":"2018","unstructured":"Martin EW, Mittag T. Relationship of sequence and phase separation in protein low-complexity regions. Biochemistry. 2018;57:2478\u201387.","journal-title":"Biochemistry"},{"key":"651_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2023.102317","volume":"75","author":"M Vendruscolo","year":"2023","unstructured":"Vendruscolo M, Fuxreiter M. Towards sequence-based principles for protein phase separation predictions. Curr Opin Chem Biol. 2023;75: 102317.","journal-title":"Curr Opin Chem Biol"},{"key":"651_CR224","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cell.2009.02.044","volume":"137","author":"S Alberti","year":"2009","unstructured":"Alberti S, Halfmann R, King O, Kapila A, Lindquist S. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell. 2009;137:146\u201358.","journal-title":"Cell"},{"key":"651_CR225","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1074\/jbc.TM118.001190","volume":"294","author":"TM Franzmann","year":"2019","unstructured":"Franzmann TM, Alberti S. Prion-like low-complexity sequences: Key regulators of protein solubility and phase behavior. J Biol Chem. 2019;294:7128\u201336.","journal-title":"J Biol Chem"},{"key":"651_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167201","volume":"434","author":"M Vendruscolo","year":"2022","unstructured":"Vendruscolo M, Fuxreiter M. Sequence determinants of the aggregation of proteins within condensates generated by liquid-liquid phase separation. J Mol Biol. 2022;434: 167201.","journal-title":"J Mol Biol"},{"key":"651_CR227","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.bpj.2010.02.006","volume":"98","author":"JA Marsh","year":"2010","unstructured":"Marsh JA, Forman-Kay JD. Sequence determinants of compaction in intrinsically disordered proteins. Biophys J. 2010;98:2383\u201390.","journal-title":"Biophys J"},{"key":"651_CR228","doi-asserted-by":"publisher","first-page":"13392","DOI":"10.1073\/pnas.1304749110","volume":"110","author":"RK Das","year":"2013","unstructured":"Das RK, Pappu RV. Conformations of intrinsically disordered proteins are influenced by linear sequence distributions of oppositely charged residues. Proc Natl Acad Sci USA. 2013;110:13392\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR229","doi-asserted-by":"crossref","unstructured":"Cascella R, Bigi A, Riffert DG, Gagliani MC, Ermini E, Moretti M, et al. A quantitative biology approach correlates neuronal toxicity with the largest inclusions of TDP-43. Sci Adv. 2022;8:eabm6376.","DOI":"10.1126\/sciadv.abm6376"},{"key":"651_CR230","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1074\/jbc.RA118.006351","volume":"294","author":"Y Chen","year":"2019","unstructured":"Chen Y, Cohen TJ. Aggregation of the nucleic acid-binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation. J Biol Chem. 2019;294:3696\u2013706.","journal-title":"J Biol Chem"},{"key":"651_CR231","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0021-9258(17)49926-1","volume":"295","author":"F Hans","year":"2020","unstructured":"Hans F, Glasebach H, Kahle PJ. Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules. J Biol Chem. 2020;295:673\u201389.","journal-title":"J Biol Chem"},{"key":"651_CR232","doi-asserted-by":"publisher","first-page":"33254","DOI":"10.1073\/pnas.2007670117","volume":"117","author":"M Hardenberg","year":"2020","unstructured":"Hardenberg M, Horvath A, Ambrus V, Fuxreiter M, Vendruscolo M. Widespread occurrence of the droplet state of proteins in the human proteome. Proc Natl Acad Sci USA. 2020;117:33254\u201362.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR233","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1074\/jbc.RA118.005889","volume":"294","author":"RL French","year":"2019","unstructured":"French RL, Grese ZR, Aligireddy H, Dhavale DD, Reeb AN, Kedia N, et al. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation. J Biol Chem. 2019;294:6696\u2013709.","journal-title":"J Biol Chem"},{"key":"651_CR234","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1002\/anie.201711854","volume":"57","author":"R Kumar","year":"2018","unstructured":"Kumar R, Das S, Mohite GM, Rout SK, Halder S, Jha NN, et al. Cytotoxic oligomers and fibrils trapped in a gel-like state of \u03b1-synuclein assemblies. Angew Chem Int Ed. 2018;57:5262\u20136.","journal-title":"Angew Chem Int Ed"},{"key":"651_CR235","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201798049","volume":"37","author":"S Wegmann","year":"2018","unstructured":"Wegmann S, Eftekharzadeh B, Tepper K, Zoltowska KM, Bennett RE, Dujardin S, et al. Tau protein liquid\u2013liquid phase separation can initiate tau aggregation. EMBO J. 2018;37: e98049.","journal-title":"EMBO J"},{"key":"651_CR236","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1038\/s41467-020-16580-3","volume":"11","author":"NM Kanaan","year":"2020","unstructured":"Kanaan NM, Hamel C, Grabinski T, Combs B. Liquid-liquid phase separation induces pathogenic tau conformations in vitro. Nat Commun. 2020;11:2809.","journal-title":"Nat Commun"},{"key":"651_CR237","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2014188118","volume":"118","author":"PEA Ash","year":"2021","unstructured":"Ash PEA, Lei S, Shattuck J, Boudeau S, Carlomagno Y, Medalla M, et al. TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau. Proc Natl Acad Sci USA. 2021;118: e2014188118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR238","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1021\/acs.jpclett.0c02567","volume":"12","author":"Y Xing","year":"2021","unstructured":"Xing Y, Nandakumar A, Kakinen A, Sun Y, Davis TP, Ke PC, et al. Amyloid Aggregation under the Lens of Liquid-Liquid Phase Separation. J Phys Chem Lett. 2021;12:368\u201378.","journal-title":"J Phys Chem Lett"},{"key":"651_CR239","doi-asserted-by":"crossref","unstructured":"Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, et al. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem. 1999;274:25945\u201352.","DOI":"10.1074\/jbc.274.36.25945"},{"key":"651_CR240","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nchembio.283","volume":"6","author":"S Campioni","year":"2010","unstructured":"Campioni S, Mannini B, Zampagni M, Pensalfini A, Parrini C, Evangelisti E, et al. A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol. 2010;6:140\u20137.","journal-title":"Nat Chem Biol"},{"key":"651_CR241","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1021\/acschemneuro.8b00141","volume":"9","author":"B Mannini","year":"2018","unstructured":"Mannini B, Habchi J, Chia S, Ruggeri FS, Perni M, Knowles TPJ, et al. Stabilization and characterization of cytotoxic A\u03b240 oligomers isolated from an aggregation reaction in the presence of zinc ions. ACS Chem Neurosci. 2018;9:2959\u201371.","journal-title":"ACS Chem Neurosci"},{"key":"651_CR242","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196056","volume":"13","author":"LB Lassen","year":"2018","unstructured":"Lassen LB, Gregersen E, Isager AK, Betzer C, Kofoed RH, Jensen PH. ELISA method to detect \u03b1-synuclein oligomers in cell and animal models. PLoS ONE. 2018;13: e0196056.","journal-title":"PLoS ONE"},{"key":"651_CR243","doi-asserted-by":"publisher","first-page":"10417","DOI":"10.1073\/pnas.1834302100","volume":"100","author":"Y Gong","year":"2003","unstructured":"Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, et al. Alzheimer\u2019s disease-affected brain: Presence of oligomeric A\u03b2 ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA. 2003;100:10417\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR244","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090857","volume":"9","author":"K Br\u00e4nnstr\u00f6m","year":"2014","unstructured":"Br\u00e4nnstr\u00f6m K, Lindhagen-Persson M, Gharibyan AL, Iakovleva I, Vestling M, Sellin ME, et al. A generic method for design of oligomer-specific antibodies. PLoS ONE. 2014;9: e90857.","journal-title":"PLoS ONE"},{"key":"651_CR245","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/alz.12457","volume":"18","author":"L Liu","year":"2022","unstructured":"Liu L, Kwak H, Lawton TL, Jin S-X, Meunier AL, Dang Y, et al. An ultra-sensitive immunoassay detects and quantifies soluble A\u03b2 oligomers in human plasma. Alzheimers Dement. 2022;18:1186\u2013202.","journal-title":"Alzheimers Dement"},{"issue":"24","key":"651_CR246","doi-asserted-by":"publisher","first-page":"13509","DOI":"10.1073\/pnas.1919464117","volume":"117","author":"FA Aprile","year":"2020","unstructured":"Aprile FA, Sormanni P, Podpolny M, Chhangur S, Needham L-M, Ruggeri FS, et al. Rational design of a conformation-specific antibody for the quantification of A\u03b2 oligomers. Proc Natl Acad Sci USA. 2020;117(24):13509\u201318.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR247","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-016-0072-9","volume":"11","author":"NK Majbour","year":"2016","unstructured":"Majbour NK, Vaikath NN, van Dijk KD, Ardah MT, Varghese S, Vesterager LB, et al. Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson\u2019s disease. Mol Neurodegener. 2016;11:7.","journal-title":"Mol Neurodegener"},{"key":"651_CR248","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105086","volume":"146","author":"ST Kumar","year":"2020","unstructured":"Kumar ST, Jagannath S, Francois C, Vanderstichele H, Stoops E, Lashuel HA. How specific are the conformation-specific \u03b1-synuclein antibodies? Characterization and validation of 16 \u03b1-synuclein conformation-specific antibodies using well-characterized preparations of \u03b1-synuclein monomers, fibrils and oligomers with distinct structures and morphology. Neurobiol Dis. 2020;146: 105086.","journal-title":"Neurobiol Dis"},{"key":"651_CR249","doi-asserted-by":"publisher","first-page":"22815","DOI":"10.1073\/pnas.2008312117","volume":"117","author":"T Chatterjee","year":"2020","unstructured":"Chatterjee T, Knappik A, Sandford E, Tewari M, Choi SW, Strong WB, et al. Direct kinetic fingerprinting and digital counting of single protein molecules. Proc Natl Acad Sci USA. 2020;117:22815\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR250","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00216-011-5207-9","volume":"401","author":"J Kool","year":"2011","unstructured":"Kool J, Jonker N, Irth H, Niessen WMA. Studying protein\u2013protein affinity and immobilized ligand\u2013protein affinity interactions using MS-based methods. Anal Bioanal Chem. 2011;401:1109.","journal-title":"Anal Bioanal Chem"},{"key":"651_CR251","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.cbpa.2005.08.013","volume":"9","author":"J Borch","year":"2005","unstructured":"Borch J, J\u00f8rgensen TJ, Roepstorff P. Mass spectrometric analysis of protein interactions. Curr Opin Chem Biol. 2005;9:509\u201316.","journal-title":"Curr Opin Chem Biol"},{"key":"651_CR252","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bfgp\/4.1.39","volume":"4","author":"J Buijs","year":"2005","unstructured":"Buijs J, Franklin GC. SPR-MS in functional proteomics. Brief Funct Genomic Proteomic. 2005;4:39\u201347.","journal-title":"Brief Funct Genomic Proteomic"},{"key":"651_CR253","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-1-60761-842-3_13","volume":"673","author":"G Zhang","year":"2010","unstructured":"Zhang G, Ueberheide BM, Waldemarson S, Myung S, Molloy K, Eriksson J, et al. Protein quantitation using mass spectrometry. Methods Mol Biol. 2010;673:211\u201322.","journal-title":"Methods Mol Biol"},{"key":"651_CR254","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nmeth.1265","volume":"5","author":"AJR Heck","year":"2008","unstructured":"Heck AJR. Native mass spectrometry: a bridge between interactomics and structural biology. Nat Methods. 2008;5:927\u201333.","journal-title":"Nat Methods"},{"key":"651_CR255","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1021\/cb500505m","volume":"9","author":"B Mannini","year":"2014","unstructured":"Mannini B, Mulvihill E, Sgromo C, Cascella R, Khodarahmi R, Ramazzotti M, et al. Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity. ACS Chem Biol. 2014;9:2309\u201317.","journal-title":"ACS Chem Biol"},{"key":"651_CR256","doi-asserted-by":"publisher","first-page":"8818","DOI":"10.1021\/acs.analchem.5b01811","volume":"87","author":"MH Horrocks","year":"2015","unstructured":"Horrocks MH, Tosatto L, Dear AJ, Garcia GA, Iljina M, Cremades N, et al. Fast flow microfluidics and single-molecule fluorescence for the rapid characterization of \u03b1-synuclein oligomers. Anal Chem. 2015;87:8818\u201326.","journal-title":"Anal Chem"},{"key":"651_CR257","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41467-018-07699-5","volume":"10","author":"R Limbocker","year":"2019","unstructured":"Limbocker R, Chia S, Ruggeri FS, Perni M, Cascella R, Heller GT, et al. Trodusquemine enhances A\u03b2 42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes. Nat Commun. 2019;10:225.","journal-title":"Nat Commun"},{"key":"651_CR258","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-020-01140-8","volume":"3","author":"R Limbocker","year":"2020","unstructured":"Limbocker R, Mannini B, Ruggeri FS, Cascella R, Xu CK, Perni M, et al. Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism. Commun Biol. 2020;3:1\u201310.","journal-title":"Commun Biol"},{"key":"651_CR259","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/13506120400014831","volume":"11","author":"AJ Modler","year":"2004","unstructured":"Modler AJ, Fabian H, Sokolowski F, Lutsch G, Gast K, Damaschun G. Polymerization of proteins into amyloid protofibrils shares common critical oligomeric states but differs in the mechanisms of their formation. Amyloid. 2004;11:215\u201331.","journal-title":"Amyloid"},{"key":"651_CR260","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1582-4934.2011.01306.x","volume":"16","author":"AR Upadhaya","year":"2012","unstructured":"Upadhaya AR, Lungrin I, Yamaguchi H, F\u00e4ndrich M, Thal DR. High-molecular weight A\u03b2 oligomers and protofibrils are the predominant A\u03b2 species in the native soluble protein fraction of the AD brain. J Cell Mol Med. 2012;16:287\u201395.","journal-title":"J Cell Mol Med"},{"key":"651_CR261","doi-asserted-by":"publisher","first-page":"35176","DOI":"10.1074\/jbc.M102223200","volume":"276","author":"G Bitan","year":"2001","unstructured":"Bitan G, Lomakin A, Teplow DB. Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem. 2001;276:35176\u201384.","journal-title":"J Biol Chem"},{"key":"651_CR262","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.abb.2019.02.001","volume":"664","author":"FS Ruggeri","year":"2019","unstructured":"Ruggeri FS, \u0160neideris T, Vendruscolo M, Knowles TPJ. Atomic force microscopy for single molecule characterisation of protein aggregation. Arch Biochem Biophys. 2019;664:134\u201348.","journal-title":"Arch Biochem Biophys"},{"key":"651_CR263","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1021\/acschembio.9b00324","volume":"14","author":"M Vivoli Vega","year":"2019","unstructured":"Vivoli Vega M, Cascella R, Chen SW, Fusco G, De Simone A, Dobson CM, et al. The toxicity of misfolded protein oligomers is independent of their secondary structure. ACS Chem Biol. 2019;14:1593\u2013600.","journal-title":"ACS Chem Biol"},{"key":"651_CR264","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.1039\/C8CC03446J","volume":"54","author":"C Capitini","year":"2018","unstructured":"Capitini C, Patel JR, Natalello A, D\u2019Andrea C, Relini A, Jarvis JA, et al. Structural differences between toxic and nontoxic HypF-N oligomers. Chem Commun. 2018;54:8637\u201340.","journal-title":"Chem Commun"},{"key":"651_CR265","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1074\/jbc.M109.069542","volume":"285","author":"JW Wu","year":"2010","unstructured":"Wu JW, Breydo L, Isas JM, Lee J, Kuznetsov YG, Langen R, et al. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation. J Biol Chem. 2010;285:6071\u20139.","journal-title":"J Biol Chem"},{"key":"651_CR266","doi-asserted-by":"publisher","first-page":"18673","DOI":"10.1074\/jbc.M113.457739","volume":"288","author":"L Gu","year":"2013","unstructured":"Gu L, Liu C, Guo Z. Structural insights into A\u03b242 oligomers using site-directed spin labeling. J Biol Chem. 2013;288:18673\u201383.","journal-title":"J Biol Chem"},{"key":"651_CR267","doi-asserted-by":"publisher","first-page":"7115","DOI":"10.1073\/pnas.0408582102","volume":"102","author":"AD Williams","year":"2005","unstructured":"Williams AD, Sega M, Chen M, Kheterpal I, Geva M, Berthelier V, et al. Structural properties of Abeta protofibrils stabilized by a small molecule. Proc Natl Acad Sci USA. 2005;102:7115\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR268","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","volume":"13","author":"CJ Swanson","year":"2021","unstructured":"Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody. Alzheimers Res Ther. 2021;13:80.","journal-title":"Alzheimers Res Ther"},{"key":"651_CR269","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3233\/JAD-140741","volume":"43","author":"S Tucker","year":"2015","unstructured":"Tucker S, M\u00f6ller C, Tegerstedt K, Lord A, Laudon H, Sj\u00f6dahl J, et al. The murine version of BAN2401 (mAb158) selectively reduces amyloid-\u03b2 protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice. J Alzheimers Dis. 2015;43:575\u201388.","journal-title":"J Alzheimers Dis"},{"key":"651_CR270","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13195-021-00838-z","volume":"13","author":"J Cummings","year":"2021","unstructured":"Cummings J, Aisen P, Lemere C, Atri A, Sabbagh M, Salloway S. Aducanumab produced a clinically meaningful benefit in association with amyloid lowering. Alzheimers Res Ther. 2021;13:98.","journal-title":"Alzheimers Res Ther"},{"key":"651_CR271","first-page":"398","volume":"8","author":"J Cummings","year":"2021","unstructured":"Cummings J, Aisen P, Apostolova LG, Atri A, Salloway S, Weiner M. Aducanumab: appropriate use recommendations. J Prev Alzheimers Dis. 2021;8:398\u2013410.","journal-title":"J Prev Alzheimers Dis"},{"key":"651_CR272","doi-asserted-by":"publisher","unstructured":"Linse S, Scheidt T, Bernfur K. et al. Kinetic fingerprints differentiate the mechanisms of action of anti-A\u03b2 antibodies. Nat Struct Mol Biol. 2020;27:1125\u201333. https:\/\/doi.org\/10.1038\/s41594-020-0505-6.","DOI":"10.1038\/s41594-020-0505-6"},{"key":"651_CR273","doi-asserted-by":"crossref","unstructured":"S\u00f6derberg L, Johannesson M, Nygren P, Laudon H, Eriksson F, Osswald G, et al. Lecanemab, Aducanumab, and Gantenerumab \u2014 binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for Alzheimer\u2019s Disease. Neurotherapeutics. 2023;20:195\u2013206.","DOI":"10.1007\/s13311-022-01308-6"},{"key":"651_CR274","doi-asserted-by":"crossref","unstructured":"Tatini F, Pugliese AM, Traini C, Niccoli S, Maraula G, Ed Dami T, et al. Amyloid-\u03b2 oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N. Neurobiol Aging. 2013;34:2100\u20139.","DOI":"10.1016\/j.neurobiolaging.2013.03.020"},{"key":"651_CR275","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40478-022-01417-5","volume":"10","author":"E Baerends","year":"2022","unstructured":"Baerends E, Soud K, Folke J, Pedersen A-K, Henmar S, Konrad L, et al. Modeling the early stages of Alzheimer\u2019s disease by administering intracerebroventricular injections of human native A\u03b2 oligomers to rats. Acta Neuropathol Commun. 2022;10:113.","journal-title":"Acta Neuropathol Commun"},{"key":"651_CR276","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease. Am J Pathol. 1999;155:853\u201362.","journal-title":"Am J Pathol"},{"key":"651_CR277","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2174\/138161212799315786","volume":"18","author":"M Kitazawa","year":"2012","unstructured":"Kitazawa M, Medeiros R, LaFerla FM. Transgenic mouse models of alzheimer disease: developing a better model as a tool for therapeutic interventions. Curr Pharm Des. 2012;18:1131\u201347.","journal-title":"Curr Pharm Des"},{"key":"651_CR278","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nn0901-887","volume":"4","author":"C Nilsberth","year":"2001","unstructured":"Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, et al. The \u201cArctic\u201d APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced Abeta protofibril formation. Nat Neurosci. 2001;4:887\u201393.","journal-title":"Nat Neurosci"},{"key":"651_CR279","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1126\/science.1213151","volume":"335","author":"A Laganowsky","year":"2012","unstructured":"Laganowsky A, Liu C, Sawaya MR, Whitelegge JP, Park J, Zhao M, et al. Atomic view of a toxic amyloid small oligomer. Science. 2012;335:1228\u201331.","journal-title":"Science"},{"key":"651_CR280","doi-asserted-by":"publisher","unstructured":"Stern AM, Yang Y, Meunier AL, Liu W, Cai Y, Ericsson M, et al. Abundant A\u03b2 fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer\u2019s disease brains. bioRxiv:2022:2022.10.18.512754. Available from:\u00a0https:\/\/doi.org\/10.1016\/j.neuron.2023.04.007.","DOI":"10.1016\/j.neuron.2023.04.007"},{"key":"651_CR281","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.nbd.2009.05.024","volume":"35","author":"JL Tomic","year":"2009","unstructured":"Tomic JL, Pensalfini A, Head E, Glabe CG. Soluble fibrillar oligomer levels are elevated in Alzheimer\u2019s disease brain and correlate with cognitive dysfunction. Neurobiol Dis. 2009;35:352\u20138.","journal-title":"Neurobiol Dis"},{"key":"651_CR282","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ana.23748","volume":"73","author":"TJ Esparza","year":"2013","unstructured":"Esparza TJ, Zhao H, Cirrito JR, Cairns NJ, Bateman RJ, Holtzman DM, et al. Amyloid-\u03b2 oligomerization in Alzheimer dementia versus high-pathology controls. Ann Neurol. 2013;73:104\u201319.","journal-title":"Ann Neurol"},{"key":"651_CR283","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/brain\/awq065","volume":"133","author":"JM McDonald","year":"2010","unstructured":"McDonald JM, Savva GM, Brayne C, Welzel AT, Forster G, Shankar GM, et al. The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain J Neurol. 2010;133:1328\u201341.","journal-title":"Brain J Neurol"},{"key":"651_CR284","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.3233\/JAD-179941","volume":"64","author":"EN Cline","year":"2018","unstructured":"Cline EN, Bicca MA, Viola KL, Klein WL. The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade. J Alzheimers Dis. 2018;64:S567\u2013610.","journal-title":"J Alzheimers Dis"},{"key":"651_CR285","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1111\/j.1742-4658.2010.07719.x","volume":"277","author":"E Pham","year":"2010","unstructured":"Pham E, Crews L, Ubhi K, Hansen L, Adame A, Cartier A, et al. Progressive accumulation of amyloid-beta oligomers in Alzheimer\u2019s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J. 2010;277:3051\u201367.","journal-title":"FEBS J"},{"issue":"13","key":"651_CR286","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.neuron.2023.04.007","volume":"111","author":"AM Stern","year":"2023","unstructured":"Stern AM, Yang Y, Jin S, Yamashita K, Meunier AL, Liu W, Cai Y, Ericsson M, Liu L, Goedert M, Scheres SHW, Selkoe DJ. Abundant A\u03b2 fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer\u2019s disease brains. Neuron. 2023;111(13):2012\u20132020.e4. https:\/\/doi.org\/10.1016\/j.neuron.2023.04.007.","journal-title":"Neuron."},{"key":"651_CR287","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1073\/pnas.0409336102","volume":"102","author":"DG Georganopoulou","year":"2005","unstructured":"Georganopoulou DG, Chang L, Nam J-M, Thaxton CS, Mufson EJ, Klein WL, et al. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2005;102:2273\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR288","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3988\/jcn.2011.7.4.215","volume":"7","author":"MJ Park","year":"2011","unstructured":"Park MJ, Cheon S-M, Bae H-R, Kim S-H, Kim JW. Elevated levels of \u03b1-synuclein oligomer in the cerebrospinal fluid of drug-na\u00efve patients with Parkinson\u2019s disease. J Clin Neurol. 2011;7:215\u201322.","journal-title":"J Clin Neurol"},{"key":"651_CR289","doi-asserted-by":"crossref","unstructured":"Tokuda T, Qureshi MM, Ardah MT, Varghese S, Shehab S a. S, Kasai T, et al. Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease. Neurology. 2010;75:1766\u201372.","DOI":"10.1212\/WNL.0b013e3181fd613b"},{"key":"651_CR290","doi-asserted-by":"crossref","unstructured":"Sideris DI, Danial JSH, Emin D, Ruggeri FS, Xia Z, Zhang YP, et al. Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer\u2019s disease. Brain Commun. 2021;3:fcab147.","DOI":"10.1093\/braincomms\/fcab147"},{"key":"651_CR291","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","volume":"136","author":"W Hong","year":"2018","unstructured":"Hong W, Wang Z, Liu W, O\u2019Malley TT, Jin M, Willem M, et al. Diffusible, highly bioactive oligomers represent a critical minority of soluble A\u03b2 in Alzheimer\u2019s disease brain. Acta Neuropathol (Berl). 2018;136:19\u201340.","journal-title":"Acta Neuropathol (Berl)"},{"key":"651_CR292","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s40478-019-0777-4","volume":"7","author":"S De","year":"2019","unstructured":"De S, Whiten DR, Ruggeri FS, Hughes C, Rodrigues M, Sideris DI, et al. Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer\u2019s disease progression. Acta Neuropathol Commun. 2019;7:120.","journal-title":"Acta Neuropathol Commun"},{"key":"651_CR293","doi-asserted-by":"publisher","first-page":"17368","DOI":"10.1038\/s41598-019-53415-8","volume":"9","author":"T Ochiishi","year":"2019","unstructured":"Ochiishi T, Kaku M, Kiyosue K, Doi M, Urabe T, Hattori N, et al. New Alzheimer\u2019s disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid \u03b2 oligomers. Sci Rep. 2019;9:17368.","journal-title":"Sci Rep"},{"key":"651_CR294","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1523\/JNEUROSCI.5825-09.2010","volume":"30","author":"T Tomiyama","year":"2010","unstructured":"Tomiyama T, Matsuyama S, Iso H, Umeda T, Takuma H, Ohnishi K, et al. A mouse model of amyloid \u03b2 oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. J Neurosci. 2010;30:4845\u201356.","journal-title":"J Neurosci"},{"key":"651_CR295","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100630","volume":"3","author":"B Kass","year":"2022","unstructured":"Kass B, Schemmert S, Zafiu C, Pils M, Bannach O, Kutzsche J, et al. A\u03b2 oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo. Cell Rep Med. 2022;3: 100630.","journal-title":"Cell Rep Med"},{"key":"651_CR296","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1016\/j.celrep.2019.10.089","volume":"29","author":"M Kiechle","year":"2019","unstructured":"Kiechle M, von Einem B, H\u00f6fs L, Voehringer P, Grozdanov V, Markx D, et al. In vivo protein complementation demonstrates presynaptic \u03b1-synuclein oligomerization and age-dependent accumulation of 8\u201316-mer oligomer species. Cell Rep. 2019;29:2862\u20132874.e9.","journal-title":"Cell Rep"},{"key":"651_CR297","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1523\/JNEUROSCI.4977-09.2010","volume":"30","author":"E Tsika","year":"2010","unstructured":"Tsika E, Moysidou M, Guo J, Cushman M, Gannon P, Sandaltzopoulos R, et al. Distinct region-specific \u03b1-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration. J Neurosci. 2010;30:3409\u201318.","journal-title":"J Neurosci"},{"key":"651_CR298","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/416507a","volume":"416","author":"M Bucciantini","year":"2002","unstructured":"Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 2002;416:507\u201311.","journal-title":"Nature"},{"key":"651_CR299","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nn1372","volume":"8","author":"JP Cleary","year":"2005","unstructured":"Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci. 2005;8:79\u201384.","journal-title":"Nat Neurosci"},{"key":"651_CR300","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1111\/j.1582-4934.2010.01239.x","volume":"15","author":"M Zampagni","year":"2011","unstructured":"Zampagni M, Cascella R, Casamenti F, Grossi C, Evangelisti E, Wright D, et al. A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells. J Cell Mol Med. 2011;15:2106\u201316.","journal-title":"J Cell Mol Med"},{"key":"651_CR301","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416:535\u20139.","journal-title":"Nature"},{"key":"651_CR302","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13024-017-0169-9","volume":"12","author":"M Arbel-Ornath","year":"2017","unstructured":"Arbel-Ornath M, Hudry E, Boivin JR, Hashimoto T, Takeda S, Kuchibhotla KV, et al. Soluble oligomeric amyloid-\u03b2 induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain. Mol Neurodegener. 2017;12:27.","journal-title":"Mol Neurodegener"},{"key":"651_CR303","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/jnc.14647","volume":"148","author":"EN Cline","year":"2019","unstructured":"Cline EN, Das A, Bicca MA, Mohammad SN, Schachner LF, Kamel JM, et al. A novel crosslinking protocol stabilizes amyloid \u03b2 oligomers capable of inducing Alzheimer\u2019s-associated pathologies. J Neurochem. 2019;148:822\u201336.","journal-title":"J Neurochem"},{"key":"651_CR304","doi-asserted-by":"publisher","first-page":"10392","DOI":"10.1074\/jbc.RA119.007743","volume":"294","author":"JM Froula","year":"2019","unstructured":"Froula JM, Castellana-Cruz M, Anabtawi NM, Camino JD, Chen SW, Thrasher DR, et al. Defining \u03b1-synuclein species responsible for Parkinson\u2019s disease phenotypes in mice. J Biol Chem. 2019;294:10392\u2013406.","journal-title":"J Biol Chem"},{"key":"651_CR305","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2105607","volume":"2019","author":"G Cenini","year":"2019","unstructured":"Cenini G, Lloret A, Cascella R. Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view. Oxid Med Cell Longev. 2019;2019: e2105607.","journal-title":"Oxid Med Cell Longev"},{"key":"651_CR306","doi-asserted-by":"publisher","first-page":"32721","DOI":"10.1038\/srep32721","volume":"6","author":"E Evangelisti","year":"2016","unstructured":"Evangelisti E, Cascella R, Becatti M, Marrazza G, Dobson CM, Chiti F, et al. Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases. Sci Rep. 2016;6:32721.","journal-title":"Sci Rep"},{"key":"651_CR307","doi-asserted-by":"publisher","first-page":"19180","DOI":"10.1038\/srep19180","volume":"6","author":"E Monsellier","year":"2016","unstructured":"Monsellier E, Bousset L, Melki R. \u03b1-Synuclein and huntingtin exon 1 amyloid fibrils bind laterally to the cellular membrane. Sci Rep. 2016;6:19180.","journal-title":"Sci Rep"},{"key":"651_CR308","doi-asserted-by":"publisher","first-page":"12479","DOI":"10.1073\/pnas.1117799109","volume":"109","author":"B Mannini","year":"2012","unstructured":"Mannini B, Cascella R, Zampagni M, van Waarde-Verhagen M, Meehan S, Roodveldt C, et al. Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers. Proc Natl Acad Sci USA. 2012;109:12479\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR309","doi-asserted-by":"crossref","unstructured":"Mannini B, Chiti F. Chaperones as suppressors of protein misfolded oligomer toxicity. Front Mol Neurosci. 2017;10:1\u20138. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5380756\/.","DOI":"10.3389\/fnmol.2017.00098"},{"key":"651_CR310","doi-asserted-by":"publisher","first-page":"24765","DOI":"10.1074\/jbc.M111.329763","volume":"287","author":"ARA Ladiwala","year":"2012","unstructured":"Ladiwala ARA, Litt J, Kane RS, Aucoin DS, Smith SO, Ranjan S, et al. Conformational Differences between two amyloid \u03b2 oligomers of similar size and dissimilar toxicity. J Biol Chem. 2012;287:24765\u201373.","journal-title":"J Biol Chem"},{"key":"651_CR311","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1073\/pnas.1209527109","volume":"109","author":"R Krishnan","year":"2012","unstructured":"Krishnan R, Goodman JL, Mukhopadhyay S, Pacheco CD, Lemke EA, Deniz AA, et al. Conserved features of intermediates in amyloid assembly determine their benign or toxic states. Proc Natl Acad Sci USA. 2012;109:11172\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR312","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1523\/JNEUROSCI.1698-16.2016","volume":"37","author":"T Yang","year":"2017","unstructured":"Yang T, Li S, Xu H, Walsh DM, Selkoe DJ. Large soluble oligomers of amyloid \u03b2-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate. J Neurosci. 2017;37:152\u201363.","journal-title":"J Neurosci"},{"key":"651_CR313","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/s41467-019-09477-3","volume":"10","author":"S De","year":"2019","unstructured":"De S, Wirthensohn DC, Flagmeier P, Hughes C, Aprile FA, Ruggeri FS, et al. Different soluble aggregates of A\u03b242 can give rise to cellular toxicity through different mechanisms. Nat Commun. 2019;10:1541.","journal-title":"Nat Commun"},{"key":"651_CR314","doi-asserted-by":"crossref","unstructured":"Evangelisti E, Cecchi C, Cascella R, Sgromo C, Becatti M, Dobson CM, et al. Membrane lipid composition and its physicochemical properties define cell vulnerability to aberrant protein oligomers. J Cell Sci. 2012;125(10):2416\u20132427.","DOI":"10.1242\/jcs.098434"},{"key":"651_CR315","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1074\/jbc.M112.400358","volume":"288","author":"JV Rushworth","year":"2013","unstructured":"Rushworth JV, Griffiths HH, Watt NT, Hooper NM. Prion protein-mediated toxicity of amyloid-\u03b2 oligomers requires lipid rafts and the transmembrane LRP1. J Biol Chem. 2013;288:8935\u201351.","journal-title":"J Biol Chem"},{"key":"651_CR316","doi-asserted-by":"crossref","unstructured":"Wang HY, Lee DH, D\u2019Andrea MR, Peterson PA, Shank RP, Reitz AB. beta-Amyloid(1\u201342) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer\u2019s disease pathology. J Biol Chem. 2000;275:5626\u201332.","DOI":"10.1074\/jbc.275.8.5626"},{"key":"651_CR317","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.3390\/ijms19071884","volume":"19","author":"B Mroczko","year":"2018","unstructured":"Mroczko B, Groblewska M, Litman-Zawadzka A, Kornhuber J, Lewczuk P. Cellular receptors of amyloid \u03b2 oligomers (A\u03b2Os) in Alzheimer\u2019s disease. Int J Mol Sci. 2018;19:1884.","journal-title":"Int J Mol Sci"},{"key":"651_CR318","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1074\/jbc.M112.400168","volume":"288","author":"ME Benoit","year":"2013","unstructured":"Benoit ME, Hernandez MX, Dinh ML, Benavente F, Vasquez O, Tenner AJ. C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-\u03b2 neurotoxicity. J Biol Chem. 2013;288:654\u201365.","journal-title":"J Biol Chem"},{"key":"651_CR319","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.3390\/ijms21124477","volume":"21","author":"Y Huang","year":"2020","unstructured":"Huang Y, Liu R. The toxicity and polymorphism of \u03b2-Amyloid oligomers. Int J Mol Sci. 2020;21:4477.","journal-title":"Int J Mol Sci"},{"key":"651_CR320","doi-asserted-by":"crossref","unstructured":"Ding Y, Zhao J, Zhang X, Wang S, Viola KL, Chow FE, et al. Amyloid beta oligomers target to extracellular and intracellular neuronal synaptic proteins in Alzheimer\u2019s disease. Front Neurol. 2019;10:1\u201316. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01140.","DOI":"10.3389\/fneur.2019.01140"},{"key":"651_CR321","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1021\/acschemneuro.0c00811","volume":"12","author":"G Fani","year":"2021","unstructured":"Fani G, Mannini B, Vecchi G, Cascella R, Cecchi C, Dobson CM, et al. A\u03b2 oligomers dysregulate calcium homeostasis by mechanosensitive activation of AMPA and NMDA receptors. ACS Chem Neurosci. 2021;12:766\u201381.","journal-title":"ACS Chem Neurosci"},{"key":"651_CR322","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1038\/s41467-021-23507-z","volume":"12","author":"L Amin","year":"2021","unstructured":"Amin L, Harris DA. A\u03b2 receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12:3451.","journal-title":"Nat Commun"},{"key":"651_CR323","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1073\/pnas.0904532106","volume":"107","author":"RP Friedrich","year":"2010","unstructured":"Friedrich RP, Tepper K, R\u00f6nicke R, Soom M, Westermann M, Reymann K, et al. Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proc Natl Acad Sci USA. 2010;107:1942\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR324","doi-asserted-by":"publisher","first-page":"10866","DOI":"10.1073\/pnas.1605104113","volume":"113","author":"M Serra-Batiste","year":"2016","unstructured":"Serra-Batiste M, Ninot-Pedrosa M, Bayoumi M, Gair\u00ed M, Maglia G, Carulla N. A\u03b242 assembles into specific \u03b2-barrel pore-forming oligomers in membrane-mimicking environments. Proc Natl Acad Sci USA. 2016;113:10866\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR325","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1038\/s41598-017-02227-9","volume":"7","author":"E Wes\u00e9n","year":"2017","unstructured":"Wes\u00e9n E, Jeffries GDM, Matson Dzebo M, Esbj\u00f6rner EK. Endocytic uptake of monomeric amyloid-\u03b2 peptides is clathrin- and dynamin-independent and results in selective accumulation of A\u03b2(1\u201342) compared to A\u03b2(1\u201340). Sci Rep. 2017;7:2021.","journal-title":"Sci Rep"},{"key":"651_CR326","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1074\/jbc.R115.702704","volume":"291","author":"HH Jarosz-Griffiths","year":"2016","unstructured":"Jarosz-Griffiths HH, Noble E, Rushworth JV, Hooper NM. Amyloid-\u03b2 receptors: the good, the bad, and the prion protein. J Biol Chem. 2016;291:3174\u201383.","journal-title":"J Biol Chem"},{"key":"651_CR327","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/ejn.12507","volume":"39","author":"EC Miller","year":"2014","unstructured":"Miller EC, Teravskis PJ, Dummer BW, Zhao X, Huganir RL, Liao D. Tau phosphorylation and tau mislocalization mediate soluble A\u03b2 oligomer-induced AMPA glutamate receptor signaling deficits. Eur J Neurosci. 2014;39:1214\u201324.","journal-title":"Eur J Neurosci"},{"key":"651_CR328","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13195-019-0541-9","volume":"11","author":"WS Shin","year":"2019","unstructured":"Shin WS, Di J, Cao Q, Li B, Seidler PM, Murray KA, et al. Amyloid \u03b2-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation. Alzheimers Res Ther. 2019;11:86.","journal-title":"Alzheimers Res Ther"},{"key":"651_CR329","doi-asserted-by":"crossref","unstructured":"Chia S, Flagmeier P, Habchi J, Lattanzi V, Linse S, Dobson CM, et al. Monomeric and fibrillar \u03b1-synuclein exert opposite effects on the catalytic cycle that promotes the proliferation of A\u03b242 aggregates. Proc Natl Acad Sci USA. 2017;114(30):8005\u201310.","DOI":"10.1073\/pnas.1700239114"},{"key":"651_CR330","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.cell.2022.05.008","volume":"185","author":"E Hallacli","year":"2022","unstructured":"Hallacli E, Kayatekin C, Nazeen S, Wang XH, Sheinkopf Z, Sathyakumar S, et al. The Parkinson\u2019s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell. 2022;185:2035\u20132056.e33.","journal-title":"Cell"},{"key":"651_CR331","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1096\/fj.04-3086fje","volume":"19","author":"M Bucciantini","year":"2005","unstructured":"Bucciantini M, Rigacci S, Berti A, Pieri L, Cecchi C, Nosi D, et al. Patterns of cell death triggered in two different cell lines by HypF-N prefibrillar aggregates. FASEB J. 2005;19:437\u20139.","journal-title":"FASEB J"},{"key":"651_CR332","doi-asserted-by":"publisher","first-page":"E1009","DOI":"10.1073\/pnas.1610586114","volume":"114","author":"M Perni","year":"2017","unstructured":"Perni M, Galvagnion C, Maltsev A, Meisl G, M\u00fcller MBD, Challa PK, et al. A natural product inhibits the initiation of \u03b1-synuclein aggregation and suppresses its toxicity. Proc Natl Acad Sci USA. 2017;114:E1009\u201317.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR333","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1021\/acschemneuro.1c00327","volume":"12","author":"S Errico","year":"2021","unstructured":"Errico S, Ramshini H, Capitini C, Canale C, Spaziano M, Barbut D, et al. Quantitative measurement of the affinity of toxic and nontoxic misfolded protein oligomers for lipid bilayers and of its modulation by lipid composition and trodusquemine. ACS Chem Neurosci. 2021;12:3189\u2013202.","journal-title":"ACS Chem Neurosci"},{"key":"651_CR334","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-02466-7","volume":"4","author":"PT Nguyen","year":"2021","unstructured":"Nguyen PT, Zottig X, Sebastiao M, Arnold AA, Marcotte I, Bourgault S. Identification of transmissible proteotoxic oligomer-like fibrils that expand conformational diversity of amyloid assemblies. Commun Biol. 2021;4:1\u201314.","journal-title":"Commun Biol"},{"key":"651_CR335","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s00018-022-04513-w","volume":"79","author":"G Fani","year":"2022","unstructured":"Fani G, La Torre CE, Cascella R, Cecchi C, Vendruscolo M, Chiti F. Misfolded protein oligomers induce an increase of intracellular Ca2+ causing an escalation of reactive oxidative species. Cell Mol Life Sci. 2022;79:500.","journal-title":"Cell Mol Life Sci"},{"key":"651_CR336","doi-asserted-by":"publisher","first-page":"17294","DOI":"10.1074\/jbc.M500997200","volume":"280","author":"A Demuro","year":"2005","unstructured":"Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem. 2005;280:17294\u2013300.","journal-title":"J Biol Chem"},{"key":"651_CR337","doi-asserted-by":"crossref","unstructured":"Limbocker R, Mannini B, Cataldi R, Chhangur S, Wright AK, Kreiser RP, et al. Rationally designed antibodies as research tools to study the structure\u2013toxicity relationship of amyloid-\u03b2 oligomers. Int J Mol Sci. 2020;21:4542.","DOI":"10.3390\/ijms21124542"},{"key":"651_CR338","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","volume":"24","author":"GH Kim","year":"2015","unstructured":"Kim GH, Kim JE, Rhie SJ, Yoon S. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol. 2015;24:325\u201340.","journal-title":"Exp Neurobiol"},{"issue":"Suppl 2","key":"651_CR339","doi-asserted-by":"publisher","first-page":"S357","DOI":"10.3233\/JAD-2010-100498","volume":"20","author":"DA Patten","year":"2010","unstructured":"Patten DA, Germain M, Kelly MA, Slack RS. Reactive oxygen species: stuck in the middle of neurodegeneration. J Alzheimers Dis. 2010;20(Suppl 2):S357\u2013367.","journal-title":"J Alzheimers Dis"},{"key":"651_CR340","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/sj.cdd.4401528","volume":"12","author":"H Kadowaki","year":"2005","unstructured":"Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K, et al. Amyloid \u03b2 induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ. 2005;12:19\u201324.","journal-title":"Cell Death Differ"},{"key":"651_CR341","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/biology10050399","volume":"10","author":"K Iuchi","year":"2021","unstructured":"Iuchi K, Takai T, Hisatomi H. Cell death via lipid peroxidation and protein aggregation diseases. Biology. 2021;10:399.","journal-title":"Biology"},{"key":"651_CR342","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1471-4159.2006.04210.x","volume":"100","author":"X Hou","year":"2007","unstructured":"Hou X, Parkington HC, Coleman HA, Mechler A, Martin LL, Aguilar M-I, et al. Transthyretin oligomers induce calcium influx via voltage-gated calcium channels. J Neurochem. 2007;100:446\u201357.","journal-title":"J Neurochem"},{"key":"651_CR343","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.bpj.2016.09.010","volume":"111","author":"L Sartiani","year":"2016","unstructured":"Sartiani L, Bucciantini M, Spinelli V, Leri M, Natalello A, Nosi D, et al. Biochemical and electrophysiological modification of amyloid transthyretin on cardiomyocytes. Biophys J. 2016;111:2024\u201338.","journal-title":"Biophys J"},{"key":"651_CR344","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/jpm12050792","volume":"12","author":"T Nakano","year":"2022","unstructured":"Nakano T, Onoue K, Terada C, Terasaki S, Ishihara S, Hashimoto Y, et al. Transthyretin amyloid cardiomyopathy: impact of transthyretin amyloid deposition in myocardium on cardiac morphology and function. J Pers Med. 2022;12:792.","journal-title":"J Pers Med"},{"key":"651_CR345","doi-asserted-by":"crossref","unstructured":"Gonzalez-Garcia M, Fusco G, De Simone A. Membrane interactions and toxicity by misfolded protein oligomers. Front Cell Dev Biol. 2021;9:1\u201312. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2021.642623.","DOI":"10.3389\/fcell.2021.642623"},{"key":"651_CR346","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.4161\/auto.30001","volume":"10","author":"M Guglielmotto","year":"2014","unstructured":"Guglielmotto M, Monteleone D, Piras A, Valsecchi V, Tropiano M, Ariano S, et al. A\u03b21-42 monomers or oligomers have different effects on autophagy and apoptosis. Autophagy. 2014;10:1827\u201343.","journal-title":"Autophagy"},{"key":"651_CR347","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13024-016-0098-z","volume":"11","author":"S S\u00f6llvander","year":"2016","unstructured":"S\u00f6llvander S, Nikitidou E, Brolin R, S\u00f6derberg L, Sehlin D, Lannfelt L, et al. Accumulation of amyloid-\u03b2 by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Mol Neurodegener. 2016;11:38.","journal-title":"Mol Neurodegener"},{"key":"651_CR348","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.neurobiolaging.2011.01.007","volume":"33","author":"MT Ferretti","year":"2012","unstructured":"Ferretti MT, Bruno MA, Ducatenzeiler A, Klein WL, Cuello AC. Intracellular A\u03b2-oligomers and early inflammation in a model of Alzheimer\u2019s disease. Neurobiol Aging. 2012;33:1329\u201342.","journal-title":"Neurobiol Aging"},{"key":"651_CR349","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/bpa.12807","volume":"30","author":"M Richter","year":"2020","unstructured":"Richter M, Vidovic N, Biber K, Dolga A, Culmsee C, Dodel R. The neuroprotective role of microglial cells against amyloid beta-mediated toxicity in organotypic hippocampal slice cultures. Brain Pathol Zurich Switz. 2020;30:589\u2013602.","journal-title":"Brain Pathol Zurich Switz"},{"key":"651_CR350","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran E, De Strooper B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov. 2022;21:306\u201318.","journal-title":"Nat Rev Drug Discov"},{"key":"651_CR351","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.bpj.2009.10.056","volume":"98","author":"CA Waudby","year":"2010","unstructured":"Waudby CA, Knowles TPJ, Devlin GL, Skepper JN, Ecroyd H, Carver JA, et al. The interaction of \u03b1b-crystallin with mature \u03b1-synuclein amyloid fibrils inhibits their elongation. Biophys J. 2010;98:843\u201351.","journal-title":"Biophys J"},{"key":"651_CR352","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.bpj.2011.07.056","volume":"101","author":"SL Shammas","year":"2011","unstructured":"Shammas SL, Waudby CA, Wang S, Buell AK, Knowles TPJ, Ecroyd H, et al. Binding of the molecular chaperone \u03b1B-Crystallin to A\u03b2 amyloid fibrils inhibits fibril elongation. Biophys J. 2011;101:1681\u20139.","journal-title":"Biophys J"},{"key":"651_CR353","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1021\/acschembio.7b01039","volume":"13","author":"F Kundel","year":"2018","unstructured":"Kundel F, De S, Flagmeier P, Horrocks MH, Kjaergaard M, Shammas SL, et al. Hsp70 inhibits the nucleation and elongation of tau and sequesters tau aggregates with high affinity. ACS Chem Biol. 2018;13:636\u201346.","journal-title":"ACS Chem Biol"},{"key":"651_CR354","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nsmb.2971","volume":"22","author":"SIA Cohen","year":"2015","unstructured":"Cohen SIA, Arosio P, Presto J, Kurudenkandy FR, Biverst\u00e5l H, Dolfe L, et al. A molecular chaperone breaks the catalytic cycle that generates toxic A\u03b2 oligomers. Nat Struct Mol Biol. 2015;22:207\u201313.","journal-title":"Nat Struct Mol Biol"},{"key":"651_CR355","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0304-3940(01)01831-6","volume":"305","author":"Y Kiuchi","year":"2001","unstructured":"Kiuchi Y, Isobe Y, Fukushima K. Entactin-induced inhibition of human amyloid \u03b2-protein fibril formation in vitro. Neurosci Lett. 2001;305:119\u201322.","journal-title":"Neurosci Lett"},{"key":"651_CR356","doi-asserted-by":"crossref","unstructured":"Dandanell\u00a0Agerschou E, Borgmann V, M.\u00a0W\u00f6rdehoff M, Hoyer W. Inhibitor and substrate cooperate to inhibit amyloid fibril elongation of \u03b1-synuclein. Chem Sci. 2020;11:11331\u20137.","DOI":"10.1039\/D0SC04051G"},{"key":"651_CR357","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3390\/biom10091323","volume":"10","author":"I Doytchinova","year":"2020","unstructured":"Doytchinova I, Atanasova M, Salamanova E, Ivanov S, Dimitrov I. Curcumin inhibits the primary nucleation of amyloid-beta peptide: a molecular dynamics study. Biomolecules. 2020;10:1323.","journal-title":"Biomolecules"},{"key":"651_CR358","doi-asserted-by":"publisher","first-page":"7992","DOI":"10.1038\/srep07992","volume":"5","author":"W-J Du","year":"2015","unstructured":"Du W-J, Guo J-J, Gao M-T, Hu S-Q, Dong X-Y, Han Y-F, et al. Brazilin inhibits amyloid \u03b2-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity. Sci Rep. 2015;5:7992.","journal-title":"Sci Rep"},{"key":"651_CR359","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1039\/D1SC05790A","volume":"13","author":"M Nagaraj","year":"2022","unstructured":"Nagaraj M, Najarzadeh Z, Pansieri J, Biverst\u00e5l H, Musteikyte G, Smirnovas V, et al. Chaperones mainly suppress primary nucleation during formation of functional amyloid required for bacterial biofilm formation. Chem Sci. 2022;13:536\u201353.","journal-title":"Chem Sci"},{"key":"651_CR360","doi-asserted-by":"crossref","unstructured":"Ghadami SA, Chia S, Ruggeri FS, Meisl G, Bemporad F, Habchi J, et al. Transthyretin inhibits primary and secondary nucleations of amyloid-\u03b2 peptide aggregation and reduces the toxicity of its oligomers. Biomacromolecules. 2020;21:1112\u201325.","DOI":"10.1021\/acs.biomac.9b01475"},{"key":"651_CR361","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.11.005","volume":"432","author":"RM Meade","year":"2020","unstructured":"Meade RM, Morris KJ, Watt KJC, Williams RJ, Mason JM. The library derived 4554w peptide inhibits primary nucleation of \u03b1-synuclein. J Mol Biol. 2020;432: 166706.","journal-title":"J Mol Biol"},{"key":"651_CR362","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1021\/acschembio.8b00466","volume":"13","author":"M Perni","year":"2018","unstructured":"Perni M, Flagmeier P, Limbocker R, Cascella R, Aprile FA, Galvagnion C, et al. Multistep inhibition of \u03b1-synuclein aggregation and toxicity in vitro and in vivo by trodusquemine. ACS Chem Biol. 2018;13:2308\u201319.","journal-title":"ACS Chem Biol"},{"key":"651_CR363","doi-asserted-by":"crossref","unstructured":"Horne RI, Andrzejewska E, Alam P, Brotzakis ZF, Srivastava A, Aubert A, et al. Discovery of potent inhibitors of \u03b1-synuclein aggregation using structure-based iterative learning. bioRxiv. 2023:2021.11.10.468009. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2021.11.10.468009v3.","DOI":"10.1101\/2021.11.10.468009"},{"key":"651_CR364","doi-asserted-by":"publisher","first-page":"E200","DOI":"10.1073\/pnas.1615613114","volume":"114","author":"J Habchi","year":"2017","unstructured":"Habchi J, Chia S, Limbocker R, Mannini B, Ahn M, Perni M, et al. Systematic development of small molecules to inhibit specific microscopic steps of A\u03b242 aggregation in Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2017;114:E200\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR365","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1700488","volume":"3","author":"FA Aprile","year":"2017","unstructured":"Aprile FA, Sormanni P, Perni M, Arosio P, Linse S, Knowles TPJ, et al. Selective targeting of primary and secondary nucleation pathways in A\u03b242 aggregation using a rational antibody scanning method. Sci Adv. 2017;3: e1700488.","journal-title":"Sci Adv"},{"key":"651_CR366","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1039\/D1NP00042J","volume":"39","author":"R Limbocker","year":"2022","unstructured":"Limbocker R, Errico S, Barbut D, Knowles TPJ, Vendruscolo M, Chiti F, et al. Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic. Nat Prod Rep. 2022;39:742\u201353.","journal-title":"Nat Prod Rep"},{"key":"651_CR367","unstructured":"FDA\u2019s Decision to Approve New Treatment for Alzheimer\u2019s Disease. FDA; 2021. Available from: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fdas-decision-approve-new-treatment-alzheimers-disease. Accessed\u00a02 Mar 2023."},{"key":"651_CR368","doi-asserted-by":"crossref","unstructured":"Krafft GA, Jerecic J, Siemers E, Cline EN. ACU193: An immunotherapeutic poised to test the amyloid \u03b2 oligomer hypothesis of alzheimer\u2019s disease. Front Neurosci. 2022;16:1-16. Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2022.848215.","DOI":"10.3389\/fnins.2022.848215"},{"key":"651_CR369","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2121966119","volume":"119","author":"S Linse","year":"2022","unstructured":"Linse S, Sormanni P, O\u2019Connell DJ. An aggregation inhibitor specific to oligomeric intermediates of A\u03b242 derived from phage display libraries of stable, small proteins. Proc Natl Acad Sci USA. 2022;119: e2121966119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR370","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nsmb.1437","volume":"15","author":"DE Ehrnhoefer","year":"2008","unstructured":"Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol. 2008;15:558\u201366.","journal-title":"Nat Struct Mol Biol"},{"key":"651_CR371","doi-asserted-by":"publisher","first-page":"24228","DOI":"10.1074\/jbc.M110.133108","volume":"285","author":"ARA Ladiwala","year":"2010","unstructured":"Ladiwala ARA, Lin JC, Bale SS, Marcelino-Cruz AM, Bhattacharya M, Dordick JS, et al. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid a\u03b2 into off-pathway conformers. J Biol Chem. 2010;285:24228\u201337.","journal-title":"J Biol Chem"},{"key":"651_CR372","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.sbi.2009.12.009","volume":"20","author":"S Connelly","year":"2010","unstructured":"Connelly S, Choi S, Johnson SM, Kelly JW, Wilson IA. Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. Curr Opin Struct Biol. 2010;20:54\u201362.","journal-title":"Curr Opin Struct Biol"},{"key":"651_CR373","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1073\/pnas.1121005109","volume":"109","author":"CE Bulawa","year":"2012","unstructured":"Bulawa CE, Connelly S, Devit M, Wang L, Weigel C, Fleming JA, et al. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci USA. 2012;109:9629\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR374","doi-asserted-by":"crossref","unstructured":"Coelho T, Maia LF, Martins da Silva A, Waddington Cruz M, Plant\u00e9-Bordeneuve V, Lozeron P, et al. Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology. 2012;79:785\u201392.","DOI":"10.1212\/WNL.0b013e3182661eb1"},{"key":"651_CR375","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379:1007\u201316.","journal-title":"N Engl J Med"},{"key":"651_CR376","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.1021\/acs.jmedchem.1c00339","volume":"64","author":"NL Yan","year":"2021","unstructured":"Yan NL, Santos-Martins D, Nair R, Chu A, Wilson IA, Johnson KA, et al. Discovery of potent coumarin-based kinetic stabilizers of amyloidogenic immunoglobulin light chains using structure-based design. J Med Chem. 2021;64:6273\u201399.","journal-title":"J Med Chem"},{"key":"651_CR377","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.sbi.2021.11.009","volume":"72","author":"F Chiti","year":"2022","unstructured":"Chiti F, Kelly JW. Small molecule protein binding to correct cellular folding or stabilize the native state against misfolding and aggregation. Curr Opin Struct Biol. 2022;72:267\u201378.","journal-title":"Curr Opin Struct Biol"},{"key":"651_CR378","doi-asserted-by":"crossref","unstructured":"Heller GT, Aprile FA, Michaels TCT, Limbocker R, Perni M, Ruggeri FS, et al. Small-molecule sequestration of amyloid-\u03b2 as a drug discovery strategy for Alzheimer\u2019s disease. Sci Adv. 6:eabb5924.","DOI":"10.1126\/sciadv.abb5924"},{"key":"651_CR379","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1021\/acschemneuro.2c00116","volume":"13","author":"T L\u00f6hr","year":"2022","unstructured":"L\u00f6hr T, Kohlhoff K, Heller GT, Camilloni C, Vendruscolo M. A small molecule stabilizes the disordered native state of the Alzheimer\u2019s A\u03b2 Peptide. ACS Chem Neurosci. 2022;13:1738\u201345.","journal-title":"ACS Chem Neurosci"},{"key":"651_CR380","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.tibs.2015.07.004","volume":"40","author":"GT Heller","year":"2015","unstructured":"Heller GT, Sormanni P, Vendruscolo M. Targeting disordered proteins with small molecules using entropy. Trends Biochem Sci. 2015;40:491\u20136.","journal-title":"Trends Biochem Sci"},{"key":"651_CR381","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-017-0077-5","volume":"6","author":"P Sweeney","year":"2017","unstructured":"Sweeney P, Park H, Baumann M, Dunlop J, Frydman J, Kopito R, et al. Protein misfolding in neurodegenerative diseases: implications and strategies. Transl Neurodegener. 2017;6:6.","journal-title":"Transl Neurodegener"},{"key":"651_CR382","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/S1474-4422(19)30202-9","volume":"18","author":"D Selkoe","year":"2019","unstructured":"Selkoe D. \u03b2-secretase inhibitors for Alzheimer\u2019s disease: heading in the wrong direction? Lancet Neurol. 2019;18:624\u20136.","journal-title":"Lancet Neurol"},{"key":"651_CR383","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1326-2-22","volume":"2","author":"SL Cole","year":"2007","unstructured":"Cole SL, Vassar R. The Alzheimer\u2019s disease \u03b2-secretase enzyme, BACE1. Mol Neurodegener. 2007;2:22.","journal-title":"Mol Neurodegener"},{"key":"651_CR384","doi-asserted-by":"publisher","first-page":"6475","DOI":"10.1038\/s41598-019-42931-2","volume":"9","author":"P Chiozzi","year":"2019","unstructured":"Chiozzi P, Sarti AC, Sanz JM, Giuliani AL, Adinolfi E, Vultaggio-Poma V, et al. Amyloid \u03b2-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine. Sci Rep. 2019;9:6475.","journal-title":"Sci Rep"},{"key":"651_CR385","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41557-018-0147-z","volume":"10","author":"Q Cao","year":"2018","unstructured":"Cao Q, Shin WS, Chan H, Vuong CK, Dubois B, Li B, et al. Inhibiting amyloid-\u03b2 cytotoxicity through its interaction with the cell surface receptor LilrB2 by structure-based design. Nat Chem. 2018;10:1213\u201321.","journal-title":"Nat Chem"},{"key":"651_CR386","doi-asserted-by":"publisher","first-page":"28625","DOI":"10.1073\/pnas.2009238117","volume":"117","author":"AR Foley","year":"2020","unstructured":"Foley AR, Roseman GP, Chan K, Smart A, Finn TS, Yang K, et al. Evidence for aggregation-independent, PrPC-mediated A\u03b2 cellular internalization. Proc Natl Acad Sci USA. 2020;117:28625\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"651_CR387","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1515\/hsz-2015-0250","volume":"397","author":"S Cappelli","year":"2016","unstructured":"Cappelli S, Penco A, Mannini B, Cascella R, Wilson MR, Ecroyd H, et al. Effect of molecular chaperones on aberrant protein oligomers in vitro: super-versus sub-stoichiometric chaperone concentrations. Biol Chem. 2016;397:401\u201315.","journal-title":"Biol Chem"},{"key":"651_CR388","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1128\/MCB.01187-10","volume":"31","author":"J Ojha","year":"2011","unstructured":"Ojha J, Masilamoni G, Dunlap D, Udoff RA, Cashikar AG. Sequestration of toxic oligomers by HspB1 as a cytoprotective mechanism. Mol Cell Biol. 2011;31:3146\u201357.","journal-title":"Mol Cell Biol"},{"key":"651_CR389","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/pro.3396","volume":"27","author":"K Garai","year":"2018","unstructured":"Garai K, Posey AE, Li X, Buxbaum JN, Pappu RV. Inhibition of amyloid beta fibril formation by monomeric human transthyretin. Protein Sci. 2018;27:1252\u201361.","journal-title":"Protein Sci"},{"key":"651_CR390","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.bbadis.2013.04.012","volume":"1832","author":"R Cascella","year":"2013","unstructured":"Cascella R, Conti S, Tatini F, Evangelisti E, Scartabelli T, Casamenti F, et al. Extracellular chaperones prevent A\u03b242-induced toxicity in rat brains. Biochim Biophys Acta. 2013;1832:1217\u201326.","journal-title":"Biochim Biophys Acta"},{"key":"651_CR391","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.bbadis.2013.09.011","volume":"1832","author":"R Cascella","year":"2013","unstructured":"Cascella R, Conti S, Mannini B, Li X, Buxbaum JN, Tiribilli B, et al. Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro. Biochim Biophys Acta BBA - Mol Basis Dis. 2013;1832:2302\u201314.","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"key":"651_CR392","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1074\/jbc.M115.689539","volume":"291","author":"M Beeg","year":"2016","unstructured":"Beeg M, Stravalaci M, Romeo M, Carr\u00e1 AD, Cagnotto A, Rossi A, et al. Clusterin binds to a\u03b21\u201342 oligomers with high affinity and interferes with peptide aggregation by inhibiting primary and secondary nucleation. J Biol Chem. 2016;291:6958\u201366.","journal-title":"J Biol Chem"},{"key":"651_CR393","doi-asserted-by":"crossref","unstructured":"Limbocker R, Staats R, Chia S, Ruggeri FS, Mannini B, Xu CK, et al. Squalamine and its derivatives modulate the aggregation of amyloid-\u03b2 and \u03b1-synuclein and suppress the toxicity of their oligomers. Front Neurosci. 2021;15:1\u201317. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.680026\/abstract.","DOI":"10.3389\/fnins.2021.680026"},{"key":"651_CR394","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.bbamem.2015.01.018","volume":"1848","author":"M Andreasen","year":"2015","unstructured":"Andreasen M, Lorenzen N, Otzen D. Interactions between misfolded protein oligomers and membranes: a central topic in neurodegenerative diseases? Biochim Biophys Acta. 2015;1848:1897\u2013907.","journal-title":"Biochim Biophys Acta"},{"key":"651_CR395","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0197-4580(01)00287-1","volume":"22","author":"RE Mrak","year":"2001","unstructured":"Mrak RE, Griffin WST. Interleukin-1, neuroinflammation, and Alzheimer\u2019s disease. Neurobiol Aging. 2001;22:903\u20138.","journal-title":"Neurobiol Aging"},{"key":"651_CR396","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fncel.2017.00216","volume":"11","author":"D Kempuraj","year":"2017","unstructured":"Kempuraj D, Thangavel R, Selvakumar GP, Zaheer S, Ahmed ME, Raikwar SP, et al. Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration. Front Cell Neurosci. 2017;11:216.","journal-title":"Front Cell Neurosci"},{"key":"651_CR397","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12974-021-02099-x","volume":"18","author":"AF Batista","year":"2021","unstructured":"Batista AF, Rody T, Forny-Germano L, Cerdeiro S, Bellio M, Ferreira ST, et al. Interleukin-1\u03b2 mediates alterations in mitochondrial fusion\/fission proteins and memory impairment induced by amyloid-\u03b2 oligomers. J Neuroinflammation. 2021;18:54.","journal-title":"J Neuroinflammation"},{"key":"651_CR398","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708300","volume":"10","author":"S Steeland","year":"2018","unstructured":"Steeland S, Gorl\u00e9 N, Vandendriessche C, Balusu S, Brkic M, Van Cauwenberghe C, et al. Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer\u2019s disease. EMBO Mol Med. 2018;10: e8300.","journal-title":"EMBO Mol Med"},{"key":"651_CR399","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40035-016-0061-5","volume":"5","author":"R Yan","year":"2016","unstructured":"Yan R. Stepping closer to treating Alzheimer\u2019s disease patients with BACE1 inhibitor drugs. Transl Neurodegener. 2016;5:13.","journal-title":"Transl Neurodegener"},{"key":"651_CR400","doi-asserted-by":"publisher","first-page":"e202200216","DOI":"10.1002\/cbic.202200216","volume":"23","author":"B Xu","year":"2022","unstructured":"Xu B, Mo X, Chen J, Yu H, Liu Y. Myricetin inhibits \u03b1-synuclein amyloid aggregation by delaying the liquid-to-solid phase transition. ChemBioChem. 2022;23:e202200216.","journal-title":"ChemBioChem"},{"key":"651_CR401","doi-asserted-by":"publisher","first-page":"31608","DOI":"10.1074\/jbc.M112.393157","volume":"287","author":"H Willander","year":"2012","unstructured":"Willander H, Presto J, Askarieh G, Biverst\u00e5l H, Frohm B, Knight SD, et al. BRICHOS domains efficiently delay fibrillation of amyloid \u03b2-peptide. J Biol Chem. 2012;287:31608\u201317.","journal-title":"J Biol Chem"},{"key":"651_CR402","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2202-11-57","volume":"11","author":"MS Wang","year":"2010","unstructured":"Wang MS, Boddapati S, Emadi S, Sierks MR. Curcumin reduces \u03b1-synuclein induced cytotoxicity in Parkinson\u2019s disease cell model. BMC Neurosci. 2010;11:57.","journal-title":"BMC Neurosci"},{"key":"651_CR403","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0969-2126(98)00022-7","volume":"6","author":"SP Smith","year":"1998","unstructured":"Smith SP, Shaw GS. A novel calcium-sensitive switch revealed by the structure of human S100B in the calcium-bound form. Structure. 1998;6:211\u201322.","journal-title":"Structure"},{"key":"651_CR404","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1038\/s41467-022-32951-4","volume":"13","author":"PM Seidler","year":"2022","unstructured":"Seidler PM, Murray KA, Boyer DR, Ge P, Sawaya MR, Hu CJ, et al. Structure-based discovery of small molecules that disaggregate Alzheimer\u2019s disease tissue derived tau fibrils in vitro. Nat Commun. 2022;13:5451.","journal-title":"Nat Commun"},{"key":"651_CR405","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104582","volume":"132","author":"DJ Schofield","year":"2019","unstructured":"Schofield DJ, Irving L, Calo L, Bogstedt A, Rees G, Nuccitelli A, et al. Preclinical development of a high affinity \u03b1-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular \u03b1-synuclein and attenuate \u03b1-synuclein spreading in vivo. Neurobiol Dis. 2019;132: 104582.","journal-title":"Neurobiol Dis"},{"key":"651_CR406","doi-asserted-by":"crossref","unstructured":"Sarkar S, C.\u00a0Rubinsztein D. Small molecule enhancers of autophagy for neurodegenerative diseases. Mol Biosyst. 2008;4:895\u2013901.","DOI":"10.1039\/b804606a"},{"key":"651_CR407","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/10715760903214454","volume":"43","author":"P Picone","year":"2009","unstructured":"Picone P, Bondi ML, Picone P, Bondi ML, Montana G, Bruno A, et al. Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: Improved delivery by solid lipid nanoparticles. Free Radic Res. 2009;43:1133\u201345.","journal-title":"Free Radic Res"},{"key":"651_CR408","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13195-015-0119-0","volume":"7","author":"HB Nygaard","year":"2015","unstructured":"Nygaard HB, Wagner AF, Bowen GS, Good SP, MacAvoy MG, Strittmatter KA, et al. A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer\u2019s disease. Alzheimers Res Ther. 2015;7:35.","journal-title":"Alzheimers Res Ther"},{"key":"651_CR409","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9719","volume":"8","author":"G Musteikyte","year":"2020","unstructured":"Musteikyte G, Ziaunys M, Smirnovas V. Methylene blue inhibits nucleation and elongation of SOD1 amyloid fibrils. PeerJ. 2020;8: e9719.","journal-title":"PeerJ"},{"key":"651_CR410","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1038\/s41467-021-26584-2","volume":"12","author":"GG Moreira","year":"2021","unstructured":"Moreira GG, Cantrelle F-X, Quezada A, Carvalho FS, Crist\u00f3v\u00e3o JS, Sengupta U, et al. Dynamic interactions and Ca2+-binding modulate the holdase-type chaperone activity of S100B preventing tau aggregation and seeding. Nat Commun. 2021;12:6292.","journal-title":"Nat Commun"},{"key":"651_CR411","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1002\/anie.201309001","volume":"53","author":"EA Mirecka","year":"2014","unstructured":"Mirecka EA, Shaykhalishahi H, Gauhar A, Akg\u00fcl \u015e, Lecher J, Willbold D, et al. Sequestration of a \u03b2-Hairpin for Control of \u03b1-Synuclein Aggregation. Angew Chem Int Ed. 2014;53:4227\u201330.","journal-title":"Angew Chem Int Ed"},{"key":"651_CR412","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1021\/acschemneuro.1c00840","volume":"13","author":"RP Kreiser","year":"2022","unstructured":"Kreiser RP, Wright AK, Sasser LR, Rinauro DJ, Gabriel JM, Hsu CM, et al. A brain-permeable aminosterol regulates cell membranes to mitigate the toxicity of diverse pore-forming agents. ACS Chem Neurosci. 2022;13:1219\u201331.","journal-title":"ACS Chem Neurosci"},{"key":"651_CR413","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2013.07.010","volume":"141","author":"MK King","year":"2014","unstructured":"King MK, Pardo M, Cheng Y, Downey K, Jope RS, Beurel E. Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments. Pharmacol Ther. 2014;141:1\u201312.","journal-title":"Pharmacol Ther"},{"key":"651_CR414","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jphs.2018.11.014","volume":"139","author":"K Fukunaga","year":"2019","unstructured":"Fukunaga K, Izumi H, Yabuki Y, Shinoda Y, Shioda N, Han F. Alzheimer\u2019s disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels. J Pharmacol Sci. 2019;139:51\u20138.","journal-title":"J Pharmacol Sci"},{"key":"651_CR415","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/febs.15340","volume":"288","author":"N Esteras","year":"2021","unstructured":"Esteras N, Kundel F, Amodeo GF, Pavlov EV, Klenerman D, Abramov AY. Insoluble tau aggregates induce neuronal death through modification of membrane ion conductance, activation of voltage-gated calcium channels and NADPH oxidase. FEBS J. 2021;288:127\u201341.","journal-title":"FEBS J"},{"key":"651_CR416","doi-asserted-by":"publisher","first-page":"9186","DOI":"10.3390\/ijms23169186","volume":"23","author":"F Dieter","year":"2022","unstructured":"Dieter F, Esselun C, Eckert GP. Redox active \u03b1-lipoic acid differentially improves mitochondrial dysfunction in a cellular model of alzheimer and its control cells. Int J Mol Sci. 2022;23:9186.","journal-title":"Int J Mol Sci"},{"key":"651_CR417","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.1074\/jbc.M413024200","volume":"280","author":"MM Dedmon","year":"2005","unstructured":"Dedmon MM, Christodoulou J, Wilson MR, Dobson CM. Heat shock protein 70 inhibits \u03b1-synuclein fibril formation via preferential binding to prefibrillar species. J Biol Chem. 2005;280:14733\u201340.","journal-title":"J Biol Chem"},{"key":"651_CR418","doi-asserted-by":"crossref","unstructured":"Dai B, Zhong T, Chen Z-X, Chen W, Zhang N, Liu X-L, et al. Myricetin slows liquid\u2013liquid phase separation of Tau and activates ATG5-dependent autophagy to suppress Tau toxicity. J Biol Chem. 2021;297;1\u201317. Available from: https:\/\/www.jbc.org\/article\/S0021-9258(21)01025-5\/abstract.","DOI":"10.1016\/j.jbc.2021.101222"},{"key":"651_CR419","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1038\/srep09649","volume":"5","author":"GAN Crespi","year":"2015","unstructured":"Crespi GAN, Hermans SJ, Parker MW, Miles LA. Molecular basis for mid-region amyloid-\u03b2 capture by leading Alzheimer\u2019s disease immunotherapies. Sci Rep. 2015;5:9649.","journal-title":"Sci Rep"},{"key":"651_CR420","doi-asserted-by":"crossref","unstructured":"Cenini G, Voos W. Mitochondria as potential targets in alzheimer disease therapy: an update. Front Pharmacol. 2019;10:1\u201320. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2019.00902.","DOI":"10.3389\/fphar.2019.00902"},{"key":"651_CR421","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119678","volume":"231","author":"X Cai","year":"2020","unstructured":"Cai X, Zhang K, Xie X, Zhu X, Feng J, Jin Z, et al. Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline. Biomaterials. 2020;231: 119678.","journal-title":"Biomaterials"},{"key":"651_CR422","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.20624","volume":"58","author":"MF Beal","year":"2005","unstructured":"Beal MF. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol. 2005;58:495\u2013505.","journal-title":"Ann Neurol"},{"key":"651_CR423","doi-asserted-by":"crossref","unstructured":"Atwal JK, Chen Y, Chiu C, Mortensen DL, Meilandt WJ, Liu Y, et al. A therapeutic antibody targeting bace1 inhibits amyloid-\u03b2 production in vivo. Sci Transl Med. 2011;3:84ra43\u201384ra43.","DOI":"10.1126\/scitranslmed.3002254"},{"key":"651_CR424","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1038\/s41598-018-24501-0","volume":"8","author":"JW Arndt","year":"2018","unstructured":"Arndt JW, Qian F, Smith BA, Quan C, Kilambi KP, Bush MW, et al. Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-\u03b2. Sci Rep. 2018;8:6412.","journal-title":"Sci Rep"},{"key":"651_CR425","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/cbic.201402430","volume":"15","author":"T Arai","year":"2014","unstructured":"Arai T, Sasaki D, Araya T, Sato T, Sohma Y, Kanai M. A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-\u03b2 oligomers. ChemBioChem. 2014;15:2577\u201383.","journal-title":"ChemBioChem"},{"key":"651_CR426","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.bbadis.2011.08.013","volume":"1812","author":"TS Anekonda","year":"2011","unstructured":"Anekonda TS, Quinn JF. Calcium channel blocking as a therapeutic strategy for Alzheimer\u2019s disease: The case for isradipine. Biochim Biophys Acta BBA - Mol Basis Dis. 2011;1812:1584\u201390.","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"key":"651_CR427","doi-asserted-by":"crossref","unstructured":"Agerschou ED, Flagmeier P, Saridaki T, Galvagnion C, Komnig D, Heid L, et al. An engineered monomer binding-protein for \u03b1-synuclein efficiently inhibits the proliferation of amyloid fibrils. eLife. 2019;8:e46112.","DOI":"10.7554\/eLife.46112"},{"key":"651_CR428","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583\u20139.","journal-title":"Nature"},{"key":"651_CR429","doi-asserted-by":"crossref","unstructured":"Collier MP, Alderson TR, de Villiers CP, Nicholls D, Gastall HY, Allison TM, et al. HspB1 phosphorylation regulates its intramolecular dynamics and mechanosensitive molecular chaperone interaction with filamin C. Sci Adv. 2019;5:eaav8421.","DOI":"10.1126\/sciadv.aav8421"},{"key":"651_CR430","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/13543784.2023.2178414","volume":"32","author":"GE Vitek","year":"2023","unstructured":"Vitek GE, Decourt B, Sabbagh MN. Lecanemab (BAN2401): an anti\u2013beta-amyloid monoclonal antibody for the treatment of Alzheimer disease. Expert Opin Investig Drugs. 2023;32:89\u201394.","journal-title":"Expert Opin Investig Drugs"},{"key":"651_CR431","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40035-018-0107-y","volume":"7","author":"X Du","year":"2018","unstructured":"Du X, Wang X, Geng M. Alzheimer\u2019s disease hypothesis and related therapies. Transl Neurodegener. 2018;7:2.","journal-title":"Transl Neurodegener"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00651-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-023-00651-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00651-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T08:09:55Z","timestamp":1708416595000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-023-00651-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":431,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["651"],"URL":"https:\/\/doi.org\/10.1186\/s13024-023-00651-2","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"2 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not directly involve human participants, human data or human tissue and therefore did not require ethical approval or consent for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.V. is a co-founder of Wren Therapeutics Limited, which is pursuing inhibitors of protein misfolding and aggregation. The remaining authors declare no competing interests. The views expressed herein are those of the authors and do not reflect the position of the United States Military Academy, the Department of the Army, or the Department of Defense.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}